 
 
 
 
[STUDY_ID_REMOVED]  
 
02-08-2016 

Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 1 of 5 1  
A R A N D O MI Z E D, D O U BL E -BLI N D E D , V E HI CL E-C O N T R OLL E D, P A R ALL EL -G R O U P, M UL TI C E N T E R 
S T U D Y T O C O M P A R E P E R RI G O U K F I N C O’ S E S T R A DI OL V A GI N AL C R E A M 0. 0 1 % T O E S T R A C E® 
( ES T R A DI OL ) V A GI N AL C R E A M, U S P,  0. 0 1 %  (W A R N E R C HIL C O T T (U S ), LL C) A N D  B O T H A C TI V E 
T R E A T M E N T S T O A V E HI CL E C O N T R OL  I N T H E T R E A T M E N T O F V UL V A R A N D V A GI N AL 
A T R O P H Y  
 
 
 
 
 
P R O T O C OL N U M B E R: P R G -N Y - 1 5-0 0 7  
 
 
 
 
 
 
C o nf i d e nti al 
 
T h e c o nfi d e nti al i nf or m ati o n pr o vi d e d i n t his d oc u m e nt is f or us e b y p arti es dir ectl y i n v ol v e d 
i n t his i n v esti g ati o n.  B y acc e pti n g t his d oc u m e nt, y o u a gr e e t h at t h e i nf or m ati o n c o nt ai n e d 
h er ei n will n ot b e discl os e d t o a n y p ers o n n ot dir ectl y i n v ol v e d i n t his i n v esti g ati o n wit h o ut 
writt e n a ut h oriz ati o n fr o m P erri g o.  
  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 3 of 5 1 T A BL E O F C O N T E N T S  
1 B A C K G R O U N D A N D R A TI O N AL E  1 2 
2 S T U D Y O BJ E C TI V E S  1 3 
2. 1 E n d p oi nts:  .................................................................................................................... 1 3  
2. 2 S af et y:  ........................................................................................................................... 1 3  
3 S T U D Y D E SI G N  1 4  
3. 1 T y p e/ D esi g n of st u d y  ................................................................................................... [ADDRESS_29232] u d y P o p ul ati o n:  ......................................................................................................... [ADDRESS_29233] N u m b er  ................................................................................... 2 0  
5. 3 D e m o gr a p hics/ M e dic al Hist or y  ................................................................................... [ADDRESS_29234] B ot h ers o m e S y m pt o m  ............................... 2 1  
5. 6 P h ysic al Ex a mi n ati o n  .................................................................................................... 2 1  
5. 7 P a p s m e ar  ..................................................................................................................... 2 2  
5. 8 V a gi n al s m e ar cyt ol o g y  ................................................................................................ 2 2  
5. 9 V a gi n al p H  .................................................................................................................... 2 2  
5. 1 0 Cli nic al l a b or at or y t ests: ............................................................................................... [ADDRESS_29235] Di ar y a n d I nstr ucti o n S h e et:  ....................................... 2 3  
5. 1 5 Visit S p ecific Pr oc e d ur es  .............................................................................................. 2 4  
5. 1 5. 1  Visit 1/ Scr e e ni n g - ( D a y -1 4 t o D a y -1)  2 4 
5. 1 5. 2  Visit 2/ R a n d o miz ati o n - ( D a y 1) 2 4 
5. 1 5. 3  Visit 3/ E n d of St u d y/ E arly T er mi n ati o n - ( D a y 8 + 3 D a ys) 2 5 
5. 1 5. 4  U nsc h e d ul e d Visit  2 5 
5. 1 6 S u m m ar y of Ass ess m e nts  ............................................................................................ 2 6  
5. 1 7 Pr ot oc ol D e vi ati o ns/ Vi ol ati o ns  .................................................................................... [ADDRESS_29236] Tr e at m e nt/ C o m pli a nc e  ................................................................................... 2 7  
5. 1 9 Disc o nti n u ati o n / Wit h dr a w al of St u d y S u bj ects  .......................................................... 2 8  
6 M A T E RI AL S A N D S U P PLI E S  2 9 
Pr ot oc ol: P R G -N Y -[ADDRESS_29237] u d y C e nt er  3 5 
7. 3. 2 S u b mitti n g a n Ex p e dit e d S af et y R e p ort t o t h e R e g ul at or y A ut h orit y  3 6 
7. 4 S A E & A Es R e q uiri n g Disc o nti n u ati o n of St u d y Dr u g, i ncl u di n g Pr e g n a nci es  .............. [ADDRESS_29238] u d y Sit e  ............................................................................ 4 6  
1 2 Q U ALI T Y C O N T R OL A N D Q U ALI T Y A S S U R A N C E  4 6 
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 5 of 5 1 1 2. 1 M o nit ori n g  .................................................................................................................... 4 6  
1 2. 2 A u diti n g  ........................................................................................................................ 4 7  
1 3 E T HI C S A N D R E S P O N SI BILI T Y  4 7 
1 4 U S E O F I N F O R M A TI O N A N D P U BLI C A TI O N  4 7 
1 5 R E F E R E N C E S  5 0  
 
 
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 6 of 5 1 S T U D Y S Y N O P SI S  
 
TI TL E:  A  R a n d o miz e d,  D o u bl e -Bli n d e d,  V e hicl e -C o ntr oll e d,  P ar all el -Gr o u p 
M ultic e nt er St u d y T o C o m p ar e P erri g o U K F I N C O’s Estr a di ol V a gi n al Cr e a m 
0. 0 1 % T o E S T R A C E® ( estr a di ol) V a gi n al Cr e a m, U S P, 0. 0 1 % (W ar n er C hilc ott 
( U S),  LL C)  A n d  B ot h  Acti v e  Tr e at m e nts  T o  A  V e hicl e  C o ntr ol  I n  T h e  
Tr e at m e nt Of V ul v ar A n d V a gi n al Atr o p h y   
 S T U D Y P E RI O D  A p pr oxi m at el y 2 2  D a ys ; u p t o [ADDRESS_29239] -tr e at m e nt f oll o w u p. 
S T U D Y 
M E DI C A TI O N  •  T est Pr o d uct:  Estr a di ol V a gi n al Cr e a m 0. 0 1 % ,  
 
        
•  R ef er e nc e Pr o d uct:  E S T R A C E® ( estr a di ol) V a gi n al Cr e a m, U S P, 0. 0 1 %, 
m a n uf act ur e d b y W ar n er C hilc ott ( U S), LL C         
•  V e hicl e:  V e hicl e of t h e t est pr o d uct,  
 
     
S T U D Y 
O BJ E C TI V E S : T o d e m o nstr at e  bi o e q uiv al e nc e  of P erri g o U K F I N C O’s E str a di ol V a gi n al 
C r e a m 0. 0 1 % c o m p ar e d wit h E S T R A C E ( e str a di ol) Va gi n al Cr e a m, U S P,  
0. 0 1 % ( W ar n er C hilc ott ( U S ), LL C) i n t h e tr e at m e nt of v ul v ar a n d v a gi n al 
atr o p h y a n d t o d e m o nstr at e  s u p eri orit y of t h e t w o acti v e tr e at m e nts o v er 
V e hicl e . 
S T U D Y D E SI G N  T his st u d y will f oll o w a r a n d o miz e d, d o u bl e -bli n d, v e hicl e -c o ntr oll e d, 
p ar all el -gr o u p d esi g n.  s u bj ects will b e r a n d o miz e d i n 
a p pr oxi m at el y [ADDRESS_29240] u d y 
o nl y aft er writt e n i nf or m e d c o ns e nt h as b e e n o bt ai n e d a n d aft er all 
i ncl usi o n/ excl usi o n crit eri a h a v e b e e n m et.  Q u alifi e d s u bj ects will b e 
r a n d o ml y assi g n e d  t o t h e T est Pr o d uct, R ef er e nc e Pr o d uct, 
or V e hicl e f or a 7 -d a y, o nc e -d ail y tr e at m e nt r e gi m e n ( Tr e at m e nt P eri o d).  
 
S T U D Y VI SI T S:  S u bj ects will visit t h e st u d y c e nt er at Visit 1/ Scr e e ni n g  ( D a y -1 4  t o D a y -1). 
At t his visit s u bj ect s will r e vi e w a n d si g n t h e st u dy s p ecific I C F, c o m pl et e a 
p h ysic al ex a m (i ncl u di n g br e ast a n d p el vic ex a m ).  T h e f oll o wi n g will als o b e 
c o n d uct e d: a n o n -f asti n g bl o o d s a m pl e, vit al si g ns, v a gi n al ultr as o u n d (f or 
all w o m e n wit h a n i nt act ut er us), v a gi n al cyt ol o g y, m a m m o gr a p h y (if o v er 
[ADDRESS_29241] u d y e nr oll m e nt), 
P a p t est (if n ot c o n d uct e d wit hi n t h e l ast 1 2 m o nt hs), a n d v a gi n al p H will b e 
o bt ai n e d.  R e vi e w of i ncl usi o n/ excl usi o n crit eri a, r e vi e w of m e dic al hist ory 
r e vi e w, r e vi e w of pri or a n d c o nc o mit a nt m e dic ati o n r e vi e w, a n d a n 
ass ess m e nt of M ost B ot h ers o m e S y m pt o m of v a gi n al a n d v ul v ar atr o p h y 
( V V A) will b e p erf or m e d. S u bj ects w ill als o b e gi v e n i nstr ucti o ns f or st u d y 
Pr ot oc ol: P R G -N Y -[ADDRESS_29242] et e at h o m e.  
 
At Visit 2/ R a n d o miz ati o n ( D a y 1)  – T h e f oll o wi n g will b e c o n d uct e d: a 
r e vi e w of i ncl usi o n/ excl usi o n crit eri a , A E’s a n d c o nc o mit a nt m e dic ati o ns. 
V it al si g ns will b e o bt ai n e d  a n d  a n ass ess m e nt of M ost B ot h ers o m e 
S y m pt o m of v a gi n al a n d v ul v ar atr o p h y ( V V A) will b e p erf or m e d  a n d 
s u bj ects will b e assi g n e d t o o n e of t h e tr e at m e nt ar ms: T est Pr o d uct, 
R ef er e nc e Pr o d uct, or V e hicl e.  
 
At Visit 3/ E n d of St u d y  - Su bj ects will h a v e a p h ysic al ex a m 
(i ncl u di n g br e ast a n d p elvic ex a m), r o uti n e bl o o d t ests o bt ai n e d, vit al si g ns 
o bt ai n e d, v a gi n al p H, v a gi n al cyt ol o g y p erf or m e d; a n d a n ass ess m e nt of 
V V A s y m pt o ms i ncl u di n g  t h e Most B ot h ers o m e S y m pt o m t h at w as 
i d e ntifi e d at b as eli n e will b e d o n e. Ad v ers e e v e nts ( A Es) a n d c o nc o mit a nt 
m e dic ati o ns will als o b e r ec or d e d. S u bj ect di ari es a n d r e m ai ni n g st u d y 
m e dic ati o n will b e c oll ect e d a n d s u bj ect s will b e disc h ar g e d fr o m t h e st u dy.  
S T U D Y 
P O P UL A TI O N:  P ost -m e n o p a us al f e m al e s u bj ects t h at m e et t h e i ncl usi o n/ excl usi o n crit eri a 
will b e e nr oll e d i n t his tri al. P ost m e n o p a us al is d efi n e d as 1 2 m o nt hs of 
s p o nt a n e o us a m e n orr h e a, 6 m o nt hs of s p o nt a n e o us a m e n orr h e a wit h 
s er u m f ollicl e-sti m ul ati n g h or m o n e ( F S H) l ev els > 4 0 mI U/ ml , [ADDRESS_29243] o my wit h F S H l ev els >  4 0 mI U/ m l. 
 s u bj ects will b e r a n d o miz e d, i n or d er t o c o m pl et e at 
l e ast  m o difi e d  i nt e nt-t o-tr e at (m I T T) s u bj ects a n d   p er -pr ot oc ol ( P P) 
s u bj ects. 
D O SI N G & 
A D MI NI S T R A TI O N  S u bj ects will b e r a n d o miz e d  t o r ec ei v e o n e of t h e t hr e e 
tr e at m e nts: Estr a di ol V a gi n al Cr e a m 0. 0 1 % ( P erri g o U K F I N C O); E S T R A C E® 
( estr a di ol) Va gi n al C r e a m, U S P, 0. 0 1 % (W ar n er C hilc ott ( U S), LL C ) or V e hicl e  
(P erri g o U K F I N C O). S u bj ects will a p pl y 2 gr a ms of t h e assi g n e d tr e at m e nt 
o nc e d ail y  i ntr a v a gi n all y at  b e d ti m e  f or 7 d a ys at a p pr oxi m at el y t h e s a m e 
ti m e e ac h d a y.  
K E Y I N CL U SI O N 
C RI T E RI A  •  S u bj ect is a p ost m e n o p a us al f e m al e a n d ot h er wis e h e alt h y , 3 0 – 7 5 
y e ars of a g e, i ncl usi v e .    
•  H as ≤  5 % s u p erfici al c ells o n v a gi n al s m e ar cyt ol o g y at Visit 
1/ Scr e e ni n g.  
•  H as a v a gi n al p H > 5. 0 at Visit 1/ Scr e e ni n g.  
•  S u bj ect s h o ul d h a v e at l e ast o n e s elf -ass e ss e d  m o d er at e t o s e v er e 
s y m pt o m of V V A fr o m t h e f oll o wi n g list t h at is i d e ntifi e d b y t h e 
s u bj ect as b ei n g t h e m ost b ot h ers o m e t o h er:  
1.  V a gi n al dr y n ess  
2.  V a gi n al a n d/ or v ul v ar irrit ati o n/itc hi n g  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 8 of 5 1 3.  D ys uri a  
4.  V a gi n al p ai n ass oci at e d wit h s ex u al acti vit y  
5.  V a gi n a l bl e e di n g ass oci at e d wit h s ex u al acti vit y (if i d e ntifi e d 
as M ost B ot h ers o m e S y m pt o m, t his  s y m pt o m is ass ess e d as 
pr es e nt)  
•  F or w o m e n wit h a n i nt act ut er us, v a gi n al ultr as o n o gr a p h y 
c o nfir m ati o n at Visit 1/ Scr e e ni n g of a n i n acti v e e n d o m etri al li ni n g 
wit h a n e n d o m etri al t hick n ess l ess t h a n 4 m m.  
•  S u bj ect s h o ul d h a v e s yst olic bl o o d pr ess ur e n o gr e at er t h a n [ADDRESS_29244] olic bl o o d pr ess ur e n o gr e at er t h a n 9 0 m m H g at Visit 
1/ Scr e e ni n g a n d at Visit 2/ R a n d o miz ati o n . 
K E Y E X CL U SI O N 
C RI T E RI A  •  U n di a g n os e d v a gi n al  bl e e di n g or a hist or y of si g nific a nt ris k f act ors 
f or e n d o m etri al c a nc er. 
•  S u bj ect h as k n o w n, s us p ect e d, or hist or y of c a nc er of t h e br e ast or 
m a m m o gr a m i n dic ati n g a n y a b n or m aliti es or s u bj ect h as a hist or y 
of c er vic al c a nc er.  
•  V a gi n al ultr as o n o gr a p h y f or a ll w o m e n wit h a n i nt act ut er us 
c o nfir mi n g e n d o m etri al t hic k n ess of 4 m m or m or e  
•  S u bj ect h as a hist or y of hy p ers e nsiti vit y or all er g y t o estr a di ol or a n y 
of t h e ot h er st u d y m e dic ati o n i n gr e di e nts.  
•  . 
•   
 
•   
. 
•  . 
•  S u bj ect is c urr e ntl y r ec eivi n g tr e at m e nt wit h estr o g e ns or r ec ei v e d 
o n e m or e r ec e ntl y t h a n t h e p eri o ds list e d u n d er S ecti o n 4. 2 of t h e 
pr ot oc ol.  
E V AL U A TI O N S  V a gi n al cyt ol o g y  a n d  v a gi n al p H, will b e e v al u at e d at D a y -1 4  t o -1 
( Scr e e ni n g) a n d D a y 8 ( E n d of St u d y).   
 
 M ost B ot h ers o m e S y m pt o m of V V A will b e e v al u at e d at  D a y -1 4 t o -1 
( Scr e e ni n g), D a y 1 ( R a n d o miz ati o n ) a n d D a y 8 ( E n d of St u d y).  
 
S af et y  will b e e v al u at e d b as e d o n s p o nt a n e o us a n d elicit e d r e p orts of 
a d v ers e e v e nts.   
E N D P OI N T S  T h e pri m ar y e n d p oi nt  of t h e st u d y is t h e pr o p orti o n of s u bj ects i d e ntifi e d 
as r es p o n d ers at  Visit 3/ E n d of St u d y. A r es p o n d er is d efi n e d as a s u bj ect 
wit h at l e ast  a 2 5 % r e d ucti o n fr o m b as eli n e  ( Visit 1/ Scr e e ni n g) i n t h e s u m 
of % ( p erc e nt) b as al/ p ar a b as al + % ( p erc e nt) i nt er m e di at e c ells o n v a gi n al 
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 9 of 5 1 cyt ol o g y A N D v a gi n al p H < 5. 0 wit h a c h a n g e fr o m Visit 1/ Scr e e ni n g   v a gi n al 
p H of at l e ast 0. 5.  
  
T h e s ec o n d ar y e n d p oi nt will b e t h e pr o p orti o n of s u bj ects wit h tr e at m e nt 
s ucc ess b as e d o n t h e i m pr o v e m e nt (c h a n g e fr o m b as eli n e ( Visit 
2/ R a n d o miz ati o n) ) of t h e M ost B ot h ers o m e S y m pt o m of V V A at Visit 3/ E n d 
of St u d y.  Tr e at m e nt s ucc ess is d efi n e d as a c h a n g e fr o m b as eli n e w hic h 
will r es ult i n a sc or e of 0 ( n o n e) or 1 ( mil d) at Visit [ADDRESS_29245] u d y.  
  
S af et y a n al ysis : T h e i nci d e nc e of all A Es r e p ort e d d uri n g t h e st u d y will b e 
s u m m ariz e d b y tr e at m e nt gr o u p. E q ui v al e nc e of t h e t est a n d r ef er e nc e 
wit h r e g ar d t o s af et y will b e e v al u at e d b y c o m p ari n g t h e n at ur e, s e v erit y 
a n d fr e q u e ncy of t h eir a d v ers e e v e nt pr ofil es.  
S T A TI S TI C AL 
M E T H O D S  D at a S ets t o b e A n al yz e d:  
 
A n I T T  s af et y s u bj ect is a n y s u bj ect w h o: ( a) was r a n d o miz e d i nt o t h e st u dy 
a n d ( b) a p pli e d at l e ast [ADDRESS_29246] u d y m e dic ati o n i ntr a v a gi n ally.  
 
A m o difi e d i nt e nt-t o-tr e at (m I T T) s u bj ect is a n y s u bj ect w h o: ( a) w as 
r a n d o miz e d i n t h e st u d y, ( b) a p pli e d at l e ast [ADDRESS_29247] u d y 
m e dic ati o n i ntr a v a gi n ally, (c) c o m pl et e d at l e ast o n e p ost r a n d o miz ati o n 
ass ess m e nt , a n d ( d) m et eli gi bilit y crit eri a. 
 
A p er -pr ot oc ol ( P P) s u bj ect , is a n y s u bj ect w h o: ( a) w as  r a n d o miz e d i n t h e 
st u d y aft er m eet i n g all i ncl usi o n/ excl usi o n crit eri a, ( b) h a d n ot t a k e n a n y 
c o nc o mit a nt m e dic ati o ns pr o hi bit e d b y t h e pr ot oc ol n or h a d a n y ot h er 
si g nific a nt pr ot oc ol vi ol ati o ns; (c) r et ur n e d f or Visit 3/ E n d of St u d y wit hi n 
t h e d esi g n at e d visit wi n d o w   wit h d at a o n th e pri m ar y effic acy 
e n d p oi nt a n d , d) h a d a c o m pli a nc e r at e  O R 
disc o nti n u e d t h e st u d y d u e t o l ac k of tr e at m e nt eff ect  
 
 
Effic acy A n al ysis:  
F or bi o e q ui v al e nc e, t h e diff er e nc e i n t h e pr o p orti o n of r es p o n d ers at Visit 
3/ E n d of St u d y will b e e v al u at e d usi n g a 2 -si d e d 9 0 % c o nfi d e nc e i nt er v al by 
W al d’s m et h o d wit h Y at es’ c o nti n uit y c orr ecti o n b as e d o n t h e d at a p o ol e d 
fr o m all cli nic al sit es f or t h e P P p o p ul ati o n. Th e t h er a p e utic e q ui v al e nc e of 
Pr ot oc ol: P R G -N Y -[ADDRESS_29248] a blis h e d if t h e 9 0 % 
c o nfi d e nc e i nt er v al is c o nt ai n e d wit hi n t h e li mits of – 0. 2 0 t o + 0. [ADDRESS_29249] atistic al s u p eri orit y t o V e hicl e  ( α 
= 0. [ADDRESS_29250] e d Z-t ests) f or pr o p orti o n of r es p o n d ers 
usi n g t h e m I T T p o p ul ati o n.  
 
S af et y A n al ysis:  
A d v ers e e v e nts will b e cl assifi e d o n t h e b asis of M e d D R A ( V ersi o n 1 8. 1 ) 
t er mi n ol o g y (s yst e m or g a n cl ass es a n d pr ef err e d t er ms) a n d s u m m ariz e d 
f or e ac h tr e at m e nt gr o u p . I nci d e nc e of a d v ers e ev e nts will b e s u m m ariz e d 
b y s yst e m or g a n cl ass a n d pr ef err e d t er m, a n d f urt h er b y s e v erit y a n d 
r el ati o ns hi p t o st u d y m e dic ati o n. Pr o p orti o ns of s u bj ects r e p orti n g a n y 
tr e at m e nt-e m er g e nt a d v ers e e v e nts will b e c o m p ar e d b et w e e n t h e 2 acti v e 
tr e at m e nts usi n g C hi-S q u ar e or Fis h er’s ex act t est if a p pr o pri at e.  
  
Pr ot oc ol: P R G -N Y -[ADDRESS_29251] I nf ecti o n  
V V A  V ul v ar  a n d V a gi n al Atr o p h y  
Pr ot oc ol: P R G -N Y -[ADDRESS_29252] or Fis h er’s Ex act t est, w hic h e v er is m ost a p pr o pri at e, will b e us e d t o c o m p ar e t h e 
pr o p orti o ns of s u bj ects i n t h e t w o acti v e tr e at m e nt gr o u ps w h o r e p ort a ny a d v ers e e v e nts.  
 
 
3  S T U D Y D E SI G N  
3. 1  T y p e/ D esi g n of st u d y  
S u bj ects i n t his m ulti -c e nt er, d o u bl e-bli n d, r a n d o miz e d, v e hicl e -c o ntr oll ed, p ar all el -gr o u p st u d y 
will b e assi g n e d  t o t est pr o d uct, r ef er e nc e pr o d uct, or v e hicl e, r es p ecti v el y. 
S u bj ects will r ec ei v e o n e  t u b e of t h e r a n d o ml y assi g n e d st u d y m e dic ati o n , whic h [ADDRESS_29253] e d 
o n v a gi n al cyt ol o g y crit eri a of l ess t h a n or e q u al t o 5 % s u p erfici al c ells a n d v a gi n al p H gr e ater 
t h a n 5. 0, w h o d o n ot h a v e c o ntr ai n dic ati o ns f or h or m o n e r e pl ac e m e nt t h er a p y wit h estr a di ol. 
S u bj ects will b e e v al u at e d at D a y 8 (aft er 7 d a ys of tr e at m e nt)  f or t h e c h a n g e i n v a gi n al 
cyt ol o g y, v a gi n al p H a n d M ost B ot h ers o m e S y m pt o m of V V A  fr o m b as eli n e. 
 
 s u bj ects will b e r a n d o miz e d t o o bt ai n a p pr oxi m at el y  m o difi e d i nt e nt-t o-
tr e at (m I T T) s u bj ects  a n d   p er -pr ot oc ol ( P P) s u bj ects.  E nr oll m e nt will 
c o nti n u e u ntil a s uffici e nt n u m b er of P P s u bj ects h a v e  b e e n o bt ai n e d .    
 
T o q u alif y f or e nr oll m e nt i n t h e st u d y , s u bj ects m ust b e h e alt h y p ost m e n o p a us al f e m al es, 
(P ost m e n o p a us al is d efi n e d as 1 2 m o nt hs of s p o nt a n e o us a m e n orr h e a or 6 m o nt hs of 
s p o nt a n e o us a m e n orr h e a wit h s er u m F S H l ev els > 4 0 mI U/ ml or [ADDRESS_29254] o my wit h F S H 
l ev els > 4 0 mI U/ ml), a n d b et w e e n t h e a g e of [ADDRESS_29255] u d y aft er i nf or m e d c o ns e nt h as b e e n 
o bt ai n e d a n d aft er all i ncl usi o n/ excl usi o n crit eri a h a v e b e e n m et .  
 
T o b e eli gi bl e f or i ncl usi o n i n t h e st u d y , s u bj ects must h a v e l ess t h a n or e q u al t o 5 % s u p erfici al 
c ells o n v a gi n al s m e ar cyt ol o g y a n d a v a gi n al p H gr e at er t h a n 5. 0.  S u bj ects s h o ul d als o h a v e at 
l e ast o n e s elf-ass ess e d m o d er at e t o s e v er e s y m pt o m of v ul v ar a n d v a gi n al atr o p h y ( V V A) o n a 
sc al e of 0 – [ADDRESS_29256] b ot h ers o m e 
t o h er ( M ost B ot h ers o m e S y m pt o m):  
 
•  V a gi n al dr y n ess  
•  V a gi n al a n d/ or v ul v ar irrit ati o n/itc hi n g  
•  D ys uri a  
•  V a gi n al p ai n ass oci at e d wit h s ex u al acti vit y  
•  V a gi n al bl e e di n g ass oci at e d wit h s ex u al ac ti vit y (if i d e ntifi e d as M ost B ot h ers o m e 
S y m pt o m  at b as eli n e , t his s y m pt o m is ass ess e d as pr es e nt) 
 
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 1 5  of 5 1 T h e s elf -ass ess e d s y m pt o ms will b e e v al u at e d o n a sc al e  of  0 = n o n e , 1 = mil d, 2 = m o d er at e a n d 
3 =s e v er e , wit h t h e exc e pti o n of v a gi n al bl e e di n g ass oci at e d wit h s ex u al acti vit y, w hic h will b e 
n ot e d as pr es e nt or a bs e nt . 
 
S u bj ects will visit t h e st u d y c e nt er at Visit 1/ Scr e e ni n g – ( D a y -1 4  t o D a y -1). At t his visit, s u bj ects 
will r e vi e w a n d si g n t h e st u d y s p ecific I C F c o m pl et e a p h ysic al ex a m (i ncl u di n g br e ast a n d p el vic 
ex a m ), a uri n e pr e g n a ncy t est will b e p erf or m e d a n d Visit 2/ R a n d o miz ati o n  will b e sc h e d ul e d .  
A n o n -f asti n g bl o o d s a m pl e, vit al si g ns, v a gi n al ultr as o u n d  (f or all w o m e n wit h a n i nt act ut er us), 
v a gi n al cyt ol o g y, m a m m o gr a p h y (if o v er [ADDRESS_29257] u d y e nr oll m e nt), P a p t est (if n ot c o n d uct e d wit hi n t h e l ast 1 2 m o nt hs),  a n d v a gi n al p H  will 
als o b e o bt ai n e d.  R e vi e w of i ncl usi o n/ excl usi o n crit eri a, m e dic al hist or y, pri or a n d c o nc o mit a nt 
m e dic ati o n s will als o b e r e vi e w e d. T h e s u bj ect will als o b e gi v e n a di ar y t o b e us e d t hr o u g h o ut 
t h e st u d y.  I n a d diti o n, a n ass ess m e nt  of M ost B ot h ers o m e S y m pt o m of v a gi n al a n d v ul v ar 
atr o p h y ( V V A) will b e p erf or m e d.  
 
At Visit 2/ R a n d o miz ati o n ( D a y 1)  – T h e f oll o wi n g pr oc e d ur es  will b e c o n d uct e d:  
i ncl usi o n/ excl usi o n crit eri a, A E’s a n d c o nc o mit a nt m e dic ati o ns will b e ass ess e d  t hr o u g h r e vi e w 
of t h e s u bj ect di ar y gi v e n at Visit [ADDRESS_29258] will b e assi g n e d t o o n e of t h e 
tr e at m e nt ar ms: T est Pr o d uct or R ef er e nc e Pr o d uct or V e hicl e. S u bj ect will  als o  b e gi v e n 
i nstr ucti o ns f or st u d y m e dic ati o n  a p plic ati o n .  
 
At Visit 3/ E n d of St u d y ( D a y 8 , + 3  d a ys)  -  S u bj ects will h a v e a p h ysic al ex a m  c o n d uct e d 
(i ncl u di n g br e ast a n d p elvic ex a m), vit al si g ns, cli nic al l a bs, v a gi n al p H, a n d v a gi n al cyt ol o g y  
c oll ect e d; a n d a n  ass ess m e nt of V V A s y m pt o ms i ncl u di n g M ost B ot h ers o m e S y m pt o m  
i d e ntifi e d.  A d v ers e e v e nts ( A Es) a n d c o nc o mit a nt m e dic ati o ns will b e r ec or d e d  I n a d diti o n, 
su bj ect di ari es a n d r e m ai ni n g st u d y m e dic ati o n will b e c oll ect e d  fr o m t h e s u bj ect pri or t o t h e 
s u bj ect b ei n g disc h ar g e d fr o m t h e st u d y.   
 
3. [ADDRESS_29259] u d y P o p ul ati o n:  
P ost -m e n o p a us al f e m al e s u bj ects t h at m e et t h e i ncl usi o n/ excl usi o n crit eri a will b e r a n d o miz e d 
i n t his tri al. P ost m e n o p a us al is d efi n e d as  1 2 m o nt hs of s p o nt a n e o us a m e n orr h e a , 6 m o nt hs of 
s p o nt a n e o us a m e n orr h e a wit h s er u m f ollicl e-sti m ul ati n g h or m o n e ( F S H) l ev els > 4 0 mI U/ ml, [ADDRESS_29260] o my wit h F S H l ev els > 4 0 mI U/ ml . 
 
 s u bj ects will b e r a n d o miz e d, i n or d er t o c o m pl et e at l e ast  m o difi e d 
i nt e nt-t o-tr e at (m I T T) s u bj ects a n d  p er -pr ot oc ol ( P P) s u bj ects.  
 
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29261] M U S T  m e et all  of t h e f oll o wi n g crit eri a:  
1.  Willi n g a n d a bl e t o u n d erst a n d a n d pr o vi d e writt e n i nf or m e d c o ns e nt .  
2.  H e alt h y p ost m e n o p a us al f e m al e s, 3 0 – 7 5 y e ars of a g e, i ncl usi v e .   
 
   
  
  
  
 
   
3.  H a v e ≤  5 % s u p erfici al c ells o n v a gi n al  s m e ar cyt ol o g y at Visit 1/ Scr e e ni n g. 
4.  H a v e a v a gi n al p H > 5. 0 at Visit 1/ Scr e e ni n g.  
5.  H a v e at l e ast o n e s elf -ass ess e d m o d er at e t o s e v er e s y m pt o m of V V A o n a sc al e of 0 
– [ADDRESS_29262] b ot h ers o m e 
t o h er:  
•  V a gi n al dr y n ess  
•  V a gi n al a n d/ or v ul v ar irrit ati o n/itc hi n g  
•  D ys uri a  
•  V a gi n al p ai n ass oci at e d wit h s ex u al acti vit y  
•  V a gi n al  bl e e di n g  ass oci at e d  wit h  s ex u al  acti vit y  (if  i d e ntifi e d  as  M ost 
B ot h ers o m e  S y m pt o m  at  Visit  / Scr e e ni n g,  t his  s y m pt o m  is  ass ess e d  as  
pr es e nt  or a bs e nt ) 
6.  F or w o m e n wit h i nt act ut er us, v a gi n al ultr as o n o gr a p h y at Visit 1 / Scr e e ni n g of a n 
i n acti v e e n d o m etri al li ni n g, wit h a n e n d o m etri al t hic k n ess l ess t h a n [ADDRESS_29263] olic bl o o d pr ess ur e is 
n o gr e at er t h a n 9 0 m m H g at Visit 1/ Scr e e ni n g a n d at Visit 2/ R a n d o miz ati o n . 
8.  F or w o m e n o v er t h e a g e of [ADDRESS_29264]  ex a mi n ati o n  at  Visit  
1/ Scr e e ni n g.  
[ADDRESS_29265] e d  wit hi n  t h e  pr e vi o us  1 2  m o nt hs  of  Visit  
1/ Scr e e ni n g/ or at Visit 1/ Scr e e ni n g wit h n o fi n di n gs t h at t h e I n v esti g at or b eli e v es 
w o ul d n ot all o w f or t h e us e of t o pic al v a gi n al estr a di ol.   Pr e vi o us P a p t est r es ults  
a n d d oc u m e nt ati o n m ust  b e a v ail a bl e  f or s u bj ects usi n g pr e vi o us r es ults. 
1 1.  I n g e n er al g o o d h e alt h wit h n o cli nic all y si g nific a nt dis e as e t h at mi g ht i nt erf er e wit h 
t h e tr e at m e nt or ass ess m e nts. 
Pr ot oc ol: P R G -N Y -[ADDRESS_29266]:  
 
1.  . 
2.  H as u n di a g n os e d  v a gi n al bl e e di n g.  
3.  F e m al es wit h a n i nt act ut er us, h a vi n g a n e n d o m etri al t hic k n ess of [ADDRESS_29267] u d y  
m e dic ati o n i n gr e di e nts. 
5.   
 
 
6.   
7.  . 
8.   
9.   
 
 
1 0.  A b n or m al P a p s m e ar wit hi n t h e pr e vi o us 1 2 m o nt hs of Visit 1/ Scr e e ni n g or o bt ai n e d 
d uri n g Visit 1/ Scr e e ni n g  a n d d e e m e d cli nic all y si g nific a nt b y t h e i n v esti g at or.  A n y 
e vi d e nc e  of  m ali g n a ncy  or  pr e m ali g n a nt  c h a n g es;  or  At y pic al  S q u a m o us  C ell  of  
U n d et er mi n e d Si g nific a nc e ( A S C -U S) P a p wit h p ositi v e hi g h ris k H P V.  
[ADDRESS_29268]’s a bilit y t o c o m pl y wit h st u d y r e q uir e m e nts a n d/ or h a v e 
dr u g or alc o h ol a d dicti o n r e q uiri n g tr e at m e nt i n t h e p ast 1 2 m o nt hs . 
1 7.  A n y cli nic all y si g nific a nt c o n diti o n or sit u ati o n (i ncl u di n g l a b or at or y v al u es) or us e of 
a n y m e dic ati o n w hic h, i n t h e o pi [INVESTIGATOR_9384] o n of t h e I n v esti g at or, mi g ht i nt erf er e wit h t h e 
c o n d uct or r es ults of t h e st u d y or pl ac e t h e pr os p ecti v e s u bj ect at i ncr e as e d ris k . 
Pr ot oc ol: P R G -N Y -[ADDRESS_29269] u g, bi ol o gic, or 
d e vic e wit hi n t h e 3 0 d a ys pri or t o Visit 1/ Scr e e ni n g.  
[ADDRESS_29270] e d i n t h e t a bl e b el o w m or e r ec e ntly t h a n t h e 
i n dic at e d p eri o d pri or t o Visit 1/ Scr e e ni n g a n d Visit 2/ R a n d o miz ati o n will excl u d e 
t h e s u bj ect i n t his st u d y: 
 
Pr o hi bit e d M e dic ati o ns  Pr o hi bit e d P eri o d Pri or t o 
Visit 1/ Scr e e ni n g a n d Visit 
2/ R a n d o miz ati o n  
  
 
 
  
  
 
  
  
  
 
  
 
  
 
 
 
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29271] u d y:  
1.  S u bj ects s h o ul d a v oi d c o nt act of t h e st u d y m e dic ati o n wit h ot h er p arts of t h e b o d y 
ot h er t h a n t h e i nt e n d e d tr e at m e nt ar e a .  
2.  W as h h a n ds b ef or e a n d aft er a p pl yi n g st u d y m e dic ati o n . Su bj ect s s h o ul d b e i nstr uct e d 
t h at t h e pr o d uct is o nl y f or i ntr a v a gi n al us e.  
3.  St or e st u d y m e dic ati o n at c o ntr oll e d r o o m t e m p er at ur e 1 5° -3 0° C ( b el o w 8 6° F). D o n ot 
r efri g er at e or fr e ez e.  
4.  K e e p t his m e dic ati o n o ut of t h e r e ac h of c hil dr e n.  
5.  S u bj ects  s h o ul d  c o ns ult  t h e  In v esti g at or  wit h  a n y  q u esti o ns  r e g ar di n g  c o nc o mit a nt  
m e dic ati o ns.  
6.  T h e pr o d uct s h o ul d n ot b e a p pli e d m or e t h a n o nc e d ail y  a n d s u bj ects s h o ul d n ot us e 
m or e t h a n t h e r ec o m m e n d e d a m o u nt.  
7.  S u bj ects s h o ul d i m m e di at el y n otif y t h e st u d y sit e st aff if t h e y ex p eri e nc e a n y u n us u al 
v a gi n al bl e e di n g d uri n g t h e st u d y.   
8.   S u bj ects s h o ul d  b e i nf or m e d t h at estr o g e n i ncr e as es t h e ris k of g all bl a d d er dis e as e or 
li v er pr o bl e ms.  S u bj ects s h o ul d n otif y t h e st u d y st aff if t h e y ex p eri e nc e a b d o mi n al p ai n, 
y ell o wi n g of t h e s ki n, e y es or n ail b e ds.  
9.  S u bj ects s h o ul d b e i nf or m e d t h at estr o g e ns m a y i ncr e as e t h e c h a nc es of g etti n g c ert ai n 
t y p es of c a nc ers, i ncl u di n g c a nc er of t h e br e ast or ut er us. 
1 0.  S u bj ects s h o ul d b e i nf or m e d t h at estr o g e n -al o n e t h er a p y i ncr e as es t h e ris k of str o k e, 
d e e p -v ei n t hr o m b osis ( D V T), pr o b a bl e d e m e nti a.  S u bj ects s h o ul d n otify st u d y st aff if 
t h e y ex p eri e nc e c h a n g es i n s p e ec h, s h ort n ess of br e at h, p ai n i n l e gs. 
[ADDRESS_29272] a n d t h e ori gi n al will b e m ai nt ai n e d b y t h e I n v esti g at or 
wit h t h e p artici p a nt’s r ec or ds.   
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29273] N u m b er  
 
 
 
 
 
  
 
5. 3  D e m o gr a p hics/ M e dic al Hist or y  
A d e m o gr a p hic pr ofil e  will b e o bt ai n e d at Visit 1/ Scr e e ni n g, w hic h i ncl u d e s d at e of birt h, r ac e 
a n d et h nicit y.  A  m e dic al hist or y will b e r ec or d e d at Visit 1/ Scr e e ni n g, w hic h  will i ncl u d e a 
c o m pl et e  r e vi e w  of  all  p ast  a n d  c urr e nt  si g nific a nt m e dic al  c o n diti o ns/ dis e as es  a n d  t h eir  
r es p ecti v e tr e at m e nts. A d et ail e d o bst etric a n d g y n ec ol o gic al m e dic al hist or y will b e o bt ai n e d 
fr o m all s u bj ects i ncl u di n g c o nfir m ati o n of p ost m e n o p a us al st at us. 
 
5. 4  C o nc o mit a nt a n d Pr o hi bit e d M e dic ati o ns  
C o nc o mit a nt m e dic ati o ns a n d a n y m e dic ati o ns t ak e n  pri or t o si g ni n g i nf or m e d 
c o ns e nt will b e r ec or d e d as pri or/c o nc o mit a nt m e dic ati o ns ( usi n g t h eir g e n eric n a m e, if k n o w n) 
wit h t h e c orr es p o n di n g i n dic ati o n. T h e m e dic ati o ns t o b e r ec or d e d will i ncl u d e pr escri pti o n ( Rx) 
a n d o v er -t h e-c o u nt er ( O T C) m e dic ati o ns a n d di et ar y s u p pl e m e nts.  All m e dic ati o ns t a k e n o n 
eit h er a r e g ul ar or as n e e d e d  b asis, i ncl u di n g vit a mi ns, as pi[INVESTIGATOR_27969] n a n d ac et a mi n o p h e n, s h o ul d b e 
r ec or d e d pri or t o c o m m e nci n g t h e us e of t h e st u d y m e dic ati o n.  A r ec or d of m e dic ati o n t a k e n 
b y t h e s u bj ect d uri n g t h e st u d y is t o b e o bt ai n e d at e ac h st u d y visit i ncl u di n g Visit 3/ E n d of 
St u d y/ D a y 8 .   
 
M e dic ati o ns/ Pr o d ucts  ( Pr escri pti o n a n d Ov er-t he- C o u nt er) pr o hi bit e d  at a n y ti m e  d uri n g t h e 
st u d y ar e list e d i n t h e f oll o wi n g t a bl e:  
 
 
 
 
  
  
 
 
 
 
 
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29274] b ot h ers o m e 
s y m pt o m at  Visit  1/ Scr e e ni n g,  Visit  2/ R a n d o miz ati o n  a n d  Visit  3/ E n d  of  St u d y/ D a y  8.   
S y m pt o ms t o b e e v al u at e d i ncl u d e:  
•  V a gi n al dr y n ess  
•  V a gi n al a n d/ or v ul v ar irrit ati o n/itc hi n g  
•  D ys uri a  
•  V a gi n al p ai n ass oci at e d wit h s ex u al acti vit y  
•  V a gi n al bl e e di n g ass oci at e d wit h s ex u al acti vit y ( a bs e nc e vs. pr es e nc e)  
 
E ac h s y m pt o m ( wit h t h e exc e pti o n of v a gi n al bl e e di n g ass oci at e d wit h s ex u al acti vit y) will b e 
sc or e d o n a sc al e of 0 t o 3, i n w hic h: 
 t 
S C O R E  A S S E S S M E N T  D E S C RI P TI O N  
[ADDRESS_29275]  
b ot h ers o m e  t o  h er.  T h e  
  
 
5. 6  P h ysic al E x a mi n ati o n  
T h e ex a m will i ncl u d e  
 
 
 
.   
 
  
 
 
 
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29276] a n d ar diz e d  pr oc e d ur e  will  b e  
p erf or m e d  at  Visit  1/ Scr e e ni n g  if  o n e  h as  n ot  b e e n  d o n e   a n d/ or  
d oc u m e nt ati o n c a n n ot b e r etri e v e d  a n d pr o vi d e d t o t h e st u d y c e nt er.  
 
5. 8  V a gi n al s m e ar c yt ol o g y  
V a gi n al cyt ol o g y will b e p erf or m e d at Visit 1/ Scr e e ni n g a n d Visit 3/ D a y 8/ E n d of St u d y. V a gi n al 
s m e ars will b e c oll ect e d  a n d e v al u at e d  
. B as al/ P ar a b as al, I nt er m e di at e a n d S u p erfici al c ells will b e c o u nt e d i n a 
fi el d u p t o 1 0 0 t ot al c ells a n d pr es e nt e d as p erc e nt a g e s.  W o m e n wit h e q u al or l ess t h a n 5 % 
s u p erfici al c ells will b e i ncl u d e d i n t his st u d y. 
 
5. 9  V a gi n al p H  
V a gi n al  p H usi n g s m e ars  will b e m e as ur e d  at Visit 
1/ Scr e e ni n g a n d Visit 3/ D a y 8/ E n d of St u d y.  T h e In v esti g at or or q u alifi e d d esi g n e e will us e 
st a n d ar diz e d p H p a p er f or ass ess m e nt of v a gi n al p H. W o m e n wit h v a gi n al p H gr e at er t h a n 5 . 0 
at Visit 1/ Scr e e ni n g will b e e nr oll e d i n t his st u d y.  
 
5. 1 0  Cli nic al l a b or at or y t ests:  
N o n -f asti n g cli nic al l a b or at or y t ests will b e o bt ai n e d at Visit 1/ Scr e e ni n g a n d at Visit 3/ E n d of 
St u d y/ D a y [ADDRESS_29277]. 
 
Cli nic al L a b or at or y T ests  
H e m at ol o g y  C h e mistr y   
    
    
   
    
    
    
    
    
    
   
  
   
Pr ot oc ol: P R G -N Y -[ADDRESS_29278] b e a v ail a bl e pri or t o Visit 2/ R a n d o miz ati o n . S u bj ects wit h cli nic ally si g nific a nt a b n or m al 
fi n di n gs o n t h e m a m m o gr a m will n ot b e e nr oll e d i n t h e st u d y. 
 
5. [ADDRESS_29279] Di ar y a n d I nstr ucti o n S h e et:  
At Visit 2/ R a n d o miz ati o n ( D a y 1), o n e   t u b e of st u d y m e dic ati o n will b e dis p e ns e d t o 
t h e e nr oll e d s u bj ects  
.  S u bj ects will b e gi v e n i nstr ucti o ns h o w t o d eliv er [ADDRESS_29280] u d y  a n d  a  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 2 5  of 5 1 5. 1 5. 3  Visit 3/ E n d of St u d y/ E arl y T er mi n ati o n - ( D a y 8 + 3 D a ys) 
 
 
 
 
   
 
  
 
 
 
 
 
5. 1 5. 4  U nsc h e d ul e d Visit  
A n u nsc h e d ul e d visit is all o w e d at a n y ti m e  if i n t h e i n v esti g at or’s o pi [INVESTIGATOR_9384] o n it is w arr a nt e d.  If t h e 
i n v esti g at or ass ess es t h e s u bj ect’s c o n diti o n a n d d et er mi n es t h at t h e s u bj ect’s c o n diti o n h as 
w ors e n e d t o t h e d e gr e e t h at it is u ns af e f or t h e s u bj ect t o c o nti n u e i n t h e st u d y, t h e s u bj ect 
m a y b e d isc o nti n u e d fr o m t h e st u d y as a tr e at m e nt f ail ur e, a n d a st a n d ar d of c ar e tr e at m e nt 
m a y b e a d vis e d at t h e i nv esti g at or’s discr eti o n. T h e f oll o wi n g pr oc e d ur es m a y b e p erf or m e d at 
t h e U nsc h e d ul e d Visit if r e q uir e d: 
 
 
 
 
  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 2 6  of 5 1 5. 1 6  S u m m ar y of Ass ess m e nts  
  
 
 
   
  
 
  
 
  
 
     
     
     
 
     
      
     
     
     
     
 
     
     
 
     
     
 
 
      
 
     
      
 
     
     
     
     
     
     
     
 
          
           
       
 
                                                   
  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 2 7  of 5 1 Scr e e n F ail ur es:  
Scr e e n f ail ur es will n ot b e i ncl u d e d i n a n y d at a a n al ys es.  A scr e e n f ail ur e is a s u bj ect w h o 
r ec ei v e d i nf or m ati o n  a b o ut  t h e  st u d y,  i ncl u di n g  si g ni n g  a n  i nf or m e d  c o ns e nt,  b ut  n e v er  
r ec ei v e d m e dic ati o n. 
 
5. 1 7  Pr ot oc ol D e vi ati o ns/ Vi ol ati o ns  
T his st u d y will b e c o n d uct e d as d escri b e d i n t his pr ot oc ol exc e pt f or a n e m er g e ncy sit u ati o n i n 
w hic h t h e pr ot ecti o n, s af et y,  a n d w ell -b ei n g  of t h e s u bj ect r e q uir es i m m e di at e i nt er v e nti o n, 
b as e d  o n  t h e  j u d g m e nt  of  t h e  i n v esti g at or  or  a  r es p o nsi bl e,  a p pr o pri at el y  tr ai n e d  a n d  
cr e d e nti al e d  pr of essi o n al(s)  d esi g n at e d  b y  t h e  i n v esti g at or.   I n  t h e  e v e nt  of  a  si g nific a nt  
d e vi ati o n fr o m  t h e pr ot oc ol d u e t o a n e m er g e ncy, acci d e nt or mist a k e, t h e i n v esti g at or or 
d esi g n e e m ust c o nt act P erri g o /  c o nt acts at t h e e arli est p ossi bl e ti m e.  
 
 
 
 
 
 
  
 
 
 
 
 
 
. 
 
 
5. [ADDRESS_29281]  Tr e at m e nt /C o m pli a nc e  
S u bj ect s wi ll s elf-a d mi nist er  i ntr a v a gi n all y   s u p pli e d st u d y m e dic ati o n o nc e d ail y f or [ADDRESS_29282] e d t o r ec or d all a p plic ati o ns m a d e or miss e d i n a di ar y 
c ar d. C o m pli a nc e will b e d et er mi n e d fr o m t h e di ar y c ar d o n Visit 3/ E n d of St u d y /D a y 8. S u bj ects  
will b e c o nsi d er e d c o m pli a nt if t h e y a p pl y  
 st u d y m e dic ati o n.  
 
 T h e t ot al n u m b er of st u d y m e dic ati o n d os es a p pli e d a n d/ or miss e d will b e 
d et er mi n e d b as e d u p o n t h e first d os e a p pli e d t hr o u g h a n d i ncl u di n g t h e l ast d os e a p pli e d. T h e 
first a n d l ast d at es of tr e at m e nt s h o ul d b e r ec or d e d o n t h e C R F. T h e t ot al of a p pli e d a n d miss e d 
st u d y m e dic ati o n a p plic ati o ns s h o ul d als o b e r ec or d e d.  By d efi niti o n t h er e ar e n o miss e d 
a p plic ati o ns b ef or e t h e first d at e of tr e at m e nt or aft er t h e l ast d at e of tr e at m e nt.   T h e n u m b er 
Pr ot oc ol: P R G -N Y -[ADDRESS_29283] u d y c o or di n at or a n d r ec or d e d o n t h e di ar y c ar d a n d o n 
t h e c o m pli a nc e p a g e of t h e c as e r e p ort f or m ( C R F). U n us e d a n d p arti ally us e d t u b es of st u d y 
m e dic ati o n  will  b e  c oll ect e d  b y  t h e  st u d y  sit e  at  Visit  3/ E n d  of  St u d y/  D a y  8  or  e arly  
t er mi n ati o n. 
 
5. 1 9  Disc o nti n u ati o n / Wit h dr a w al of St u d y S u bj ects  
S u bj ects m a y b e r e m o v e d fr o m t h e st u d y f or a n y of t h e f oll o wi n g r e as o ns:  
•  T h e s u bj ect wit h dr a ws h er c o ns e nt f or a n y r e as o n.  
•  T h e s u bj ect’s c o n diti o n h as w ors e n e d t o t h e d e gr e e t h at  t h e i n v esti g at or f e els it is u ns af e 
f or t h e s u bj ect t o c o nti n u e i n t h e st u d y. 
•  T h e s u bj ect’s m e dic ati o n c o d e is u n bli n d e d.  
•  A n a d v ers e e v e nt occ urs f or w hic h t h e s u bj ect d esir es t o disc o nti n u e tr e at m e nt or t h e 
i n v esti g at or d et er mi n es t h at it is i n t h e s u bj ect’s b est i nt er est t o b e disc o nti n u e d. 
•  T h e s u bj ect is l ost t o f oll o w -u p.  T h e i n v esti g at or will d oc u m e nt eff orts t o att e m pt t o r e ac h 
t h e s u bj ect t wic e b y t el e p h o n e a n d will s e n d a c ertifi e d f oll o w-u p l ett er b ef or e c o nsi d eri n g 
t h at s u bj ect l ost t o f oll o w-u p . All att e m pts m ust b e t h or o u g hl y r ec or d e d. 
•  T h er e is a si g nific a nt pr ot oc ol vi ol ati o n  as d escri b e d i n S ecti o n 5. 1 8 . 
•  A c o nc o mit a nt t h er a p y is r e p ort e d or r e q uir e d t h at is li k el y t o i nt erf er e wit h t h e r es ult of 
t h e st u d y. 
•  I ns uffici e nt t h er a p e utic r es p o ns e  
 
T h e r e as o ns f or a s u bj ect b ei n g disc o nti n u e d will b e d oc u m e nt e d i n t h e C R F  a n d t h e e nr oll m e nt  
l o g.  If a s u bj ect is disc o nti n u e d fr o m t h e st u dy f or a n y r e as o n, t h e E arl y T er mi n ati o n Visit 
pr oc e d ur es s h o ul d b e c o m pl et e d a n d a n y o utst a n di n g d at a a n d st u d y m e dic ati o n s h o ul d b e 
c oll ect e d.  D at a, i n a d diti o n t o t h e r e as o n f or disc o nti n u ati o n a n d t h e d a t e of r e m o v al, will b e 
r ec or d e d o n t h e E n d of St u d y C R F . 
 
I n t h e e v e nt t h at a s u bj ect disc o nti n u es fr o m t h e st u d y at a n y ti m e d u e t o a n a d v ers e e v e nt, t h e 
r e as o n  f or  disc o nti n u ati o n,  t h e  n at ur e  of  t h e  e v e nt  a n d  its  cli nic al  c o urs e  m ust  b e  f ull y  
d oc u m e nt e d.   F or s uc h a s u bj ect, t h e i n v esti g at or m ust stri v e t o f oll o w t h e s u bj ect u ntil t h e 
a d v ers e e v e nt h as r es ol v e d, b ec o m e cli nic all y i nsi g nific a nt, is st a biliz e d, or t h e s u bj ect is l ost t o 
f oll o w-u p.  
 
 
 
 
 
 
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29284] of:  
 
T est Pr o d uct :   Estr a di ol V a gi n al Cr e a m 0. 0 1 %   
        
                                       
       
 
           R ef er e nc e Pr o d uct : E S T R A C E® (Estr a di ol ) V a gi n al Cr e a m, U S P, 0. 0 1 %  
M a n uf act ur e d b y: W ar n er C hilc ott ( U S), LL C  
 
V e hicl e :   Estr a di ol V a gi n al Cr e a m 0. 0 1 % – V e hicl e    
   
 
6. [ADDRESS_29285](s) will b e disc o nti n u e d fr o m t h e st u d y a n d t h e r e as o n will b e n ot e d o n t h e s o urc e 
d oc u m e nt a n d C R F.  
 
T h e t e ar -off p orti o n h as a n a d h esi v e b ac ki n g t o affix t o t h e st u d y m e dic ati o n dis p e nsi n g l o g t h at 
will b e m ai nt ai n e d at t h e i n v esti g at or sit e. T h e i n di vi d u al b ox es ar e n u m b er e d s e q u e nti all y a n d 
s h o ul d b e dis p e ns e d i n or d er. 
 
 
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29286] eti o n. ( N ot e: S u bj ect  d at a d o es n ot i ncl u d e t h e c oll ecti o n of i niti al b as eli n e 
m e dic al hist or y, c o nt act i nf or m ati o n, or i nf or m e d c o ns e nt, etc., o nl y t h os e it e ms/ acti viti es t h at 
m a y r es ult i n t h e i n d e p e n d e nt t hir d p art y dis p e ns er b ec o mi n g bi as e d s h o ul d b e a v oi d e d).   T h e 
i n v esti g at or p erf or mi n g t h e cli nic al e v al u ati o ns will n ot dis p e ns e or c oll ect st u d y m e dic ati o n.  
 
T h e  I n v esti g at or  m ust  n ot  u nc o v er  t h e  bli n d e d  pr o d uct  i d e ntific ati o n  u nl ess  a bs ol ut el y  
n ec ess ar y t o s u p p ort m e dic al tr e at m e nt i n a n e m er g e ncy. T h e M e dic al M o nit or or  S p o ns or 
s h o ul d b e c o nt act e d pri or t o br e a ki n g t h e bli n d, or as s o o n as p ossi bl e t h er e aft er, if s uc h a n 
e v e nt occ urs. If t h e st u d y bli n d is br o k e n f or a n y s u bj ect, f or a n y r e as o n, t h e s u bj ect will b e 
disc o nti n u e d fr o m t h e st u d y a n d t h e r e as o n r ec or d e d.  
  
6. 2. [ADDRESS_29287] u d y m e dic ati o n r ec ei v e d.  As p er t h e 
C o d e of F e d er al R e g ul ati o ns P art 2 1, S ecti o n 3 2 0. 3 8( e), “ E ac h r es er v e s a m pl e s h all b e st or e d 
u n d er c o n diti o ns c o nsist e nt wit h pr o d uct l a b eli n g a n d i n a n ar e a s e gr e g at e d fr o m t h e ar e a 
w h er e t esti n g is c o n d uct e d a n d wit h acc ess li mit e d t o a ut h oriz e d p ers o n n el. E ac h r es er v e 
s a m pl e s h all b e r et ai n e d f or a p eri o d of at l e ast [ADDRESS_29288] e w as o bt ai n e d w as 
us e d.”  T h e  i n v esti g at or  will  st or e  t h e  r et ai n  s a m pl e  st u d y  m e dic ati o n  u ntil  s uc h  ti m e  as  
n otific ati o n is r ec ei v e d fr o m P erri g o t h at t h e s a m pl es ar e n o l o n g er r e q uir e d.  
 
6. 2. [ADDRESS_29289] e d fr o m t e m p er at ur e i n 
exc ess  of  4 0° C  ( 1 0 4° F).  E ac h  i n v esti g at or  si t e  will  e ns ur e  t h at  t h e  t e m p er at ur e  of  st u d y  
m e dic ati o n is m o nit or e d a n d r ec or d e d t hr o u g h o ut t h e st u d y. T h e m e dic ati o n s h o ul d n ot b e 
fr oz e n, s h o ul d b e pr ot ect e d fr o m h e at a n d k e pt ti g htl y cl os e d.  T h e i n v esti g at or will n ot s u p ply 
st u d y t est articl es t o a ny p ers o n n ot e nr oll e d i n t his st u d y, or t o a n y p h ysici a n or sci e ntist 
exc e pt t h os e n a m e d as s u b -i n v esti g at ors.  
 
T h e cli nic p ers o n n el will k e e p a r u n ni n g i n v e nt or y of st u d y t est articl es dis p e ns e d t h at will 
i ncl u d e s u bj ect n u m b ers assi g n e d a n d t h e d at e e ac h is dis p e ns e d a n d us e d.  A st u d y m e dic ati o n 
Pr ot oc ol: P R G -N Y -[ADDRESS_29290]: R ef er e nc e: V e hicl e   
. 
 
6. 2. [ADDRESS_29291] u d y m o nit ors, a n d d at a 
a n al ysis/ m a n a g e m e nt p ers o n n el ar e bli n d e d t o t h e s u bj ect assi g n m e nt. I n t h e e v e nt of a n 
e m er g e ncy, t h e s p ecific s u bj ect tr e at m e nt m a y b e i d e ntifi e d b y r e m o vi n g t h e o v erl a y of t h e 
bli n d e d l a b el , w hic h is att ac h e d t o t h e st u d y m e dic ati o n l o g; h o w e v er, e v er y eff ort s h o ul d b e 
m a d e t o m ai nt ai n t h e bli n d.  T h e i n v esti g at or m ust n ot scr atc h off t h e occl u di n g l a y er of t h e 
l a b el u nl ess a bs ol ut el y n ec ess ar y t o pr o vi d e m e dic al tr e at m e nt t o a s u bj ect i n a n e m er g e nc y 
sit u ati o n o nl y a n d s h o ul d s e e k pri or a ut h oriz ati o n b y P erri g o or d esi g n e e w h e n p ossi bl e.  T h e 
r e as o n f or br e a ki n g t h e bli n d m ust b e cl e arl y d oc u m e nt e d i n t h e s o urc e d oc u m e nt ati o n a n d 
C R F a n d t h e s u bj ect m ust b e disc o nti n u e d fr o m t h e st u d y .  
 
[ADDRESS_29292] u d y is t h e p ac k a g e i ns ert f or Estr ac e ® ( Estr a di ol) V a gi n al Cr e a m, 0. 0 1 %.   
 
T h e p ot e nti al a d v ers e r e acti o ns of g e n eric estr a di ol v a gi n al cr e a m 0. 0 1 % ar e a ntici p at e d t o b e 
si mil ar t o t h os e o bs er v e d wit h Estr ac e ® ( Estr a di ol) V a gi n al Cr e a m, 0. 0 1 %. A d v ers e r e acti o ns 
r el at e d t o tr e at m e nt wit h Estr ac e ® ( Estr a di ol) V a gi n al Cr e a m 0. 0 1 % i ncl u d e b ox e d w ar ni n g s f or: 
•  I ncr e as e d ris k of e n d o m etri al c a nc er,  
•  C ar di o v asc ul ar a n d ot h er ris ks: m y oc ar di al i nf arcti o n, str o k e, i n v asi v e br e ast c a nc er, 
p ul m o n ar y e m b oli, a n d d e e p v e n o us t hr o m b osis i n p ost m e n o p a us al w o m e n ( 5 0 t o 7 9 
y e ars of a g e) d uri n g 5 y e ars of tr e at m e nt wit h or al  c o nj u g at e d estr o g e ns ( C E 0. 6 2 5 m g) 
c o m bi n e d wit h m e dr oxy pr o g est er o n e ac et at e ( M P A 2. 5 m g) r el ati v e t o V e hicl e . 
•  I ncr e as e d ris k of d e v el o pi n g pr o b a bl e d e m e nti a i n p ost m e n o p a us al w o m e n [ADDRESS_29293] er o n e ac et at e r el ati v e t o V e hicl e . 
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29294] e mic a bs or pti o n m a y occ ur wit h t h e us e of E S T R A C E® (Estr a di ol ) V a gi n al Cr e a m,  U S P, 0. 0 1 %. 
T h e  w ar ni n gs,  pr ec a uti o ns,  a n d  a d v ers e  r e acti o ns  ass oci at e d  wit h  or al  estr o g e n  tr e at m e nt  
s h o ul d b e t a k e n i nt o acc o u nt. 
 
T h e f oll o wi n g a d diti o n al a d v ers e r e acti o ns h a v e b e e n r e p ort e d wit h estr o g e n a n d/ or pr o g esti n 
t h er ap y:  
 
G e nit o uri n ar y s yst e m  
C h a n g es i n v a gi n al bl e e di n g p att er n a n d a b n or m al wit h dr a w al bl e e di n g or fl o w; br e a kt hr o u g h 
bl e e di n g; s p otti n g; d ys m e n orr h e a, i ncr e as e i n siz e of ut eri n e l ei o m y o m at a; v a gi nitis, i ncl u di n g 
v a gi n al  c a n di di asis;  c h a n g e  i n  a m o u nt  of  c er vic al  s ecr eti o n;  c h a n g es  i n  c er vic al  ectr o pi o n;  
a p plic ati o n sit e r e acti o ns of v ul v o v a gi n al disc o mf ort i ncl u di n g b ur ni n g a n d irrit ati o n; g e nit al 
pr urit us; o v ari a n c a nc er; e n d o m etri al h y p er pl asi a; e n d o m etri al c a nc er.  
 
Br e asts  
T e n d er n ess,  e nl ar g e m e nt,  p ai n,  ni p pl e  disc h ar g e,  g al act orr h e a;  fi br ocystic  br e ast  c h a n g es;  
br e ast c a nc er.  
 
C ar di o v asc ul ar  
D e e p a n d s u p erfici al v e n o us t hr o m b osis; p ul m o n ar y e m b olis m; t hr o m b o p hl e bitis; m y oc ar di al 
i nf arcti o n; str o k e; i ncr e as e i n bl o o d pr essur e.  
 
G astr oi nt esti n al  
N a us e a, v o miti n g;  a b d o mi n al cr a m ps, bl o ati n g; c h ol est atic j a u n dic e; i ncr e as e d  i nci d e nc e  of 
g all bl a d d er dis e as e; p a ncr e atitis, e nl ar g e m e nt of h e p atic h e m a n gi o m as.  
 
S ki n  
C hl o as m a  or  m el as m a,  t h at  m a y  p ersist  w h e n  dr u g  is  disc o nti n u e d;  er yt h e m a  m ultif or m e;  
er yt h e m a n o d os u m; h e m orr h a gic er u pti o n; l oss of sc al p h air; hirs utis m; pr urit us, r as h.  
 
E y es  
R eti n al v asc ul ar t hr o m b osis, i nt ol er a nc e t o c o nt act l e ns es.  
 
C e ntr al n er v o us s yst e m  
H e a d ac h e; mi gr ai n e; dizzi n ess; m e nt al d e pr essi o n; c h or e a; n er v o us n ess; m o o d dist ur b a nc es; 
irrit a bilit y; ex ac er b ati o n of e pil e ps y, d e m e nti a.  
 
Misc ell a n e o us  
I ncr e as e  or d ecr e as e  i n w ei g ht; r e d uc e d c ar b o h y dr at e  t ol er a nc e;  a g gr a v ati o n of p or p h yri a; 
e d e m a;  art hr al gi as;  l e g  cr a m ps;  c h a n g es  i n  li bi d o;  urtic ari a,  a n gi o e d e m a,  h y p ers e nsiti vit y,  
a n a p h yl act oi d/ a n a p h yl actic r e acti o ns;  h y p oc alc e mi a;  ex ac er b ati o n  of  ast h m a;  i ncr e as e d  
tri gl yc eri d es.  
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29295] t h e M e dic al M o nit or or P erri g o b y t el e p h o n e a n d f oll o w u p wit h a 
writt e n d escri pti o n as s o o n as p ossi bl e.  T h e o v ers e ei n g I R B s h o ul d als o b e n otifi e d.  
 
7. 2  D efi niti o ns  
A n a d v ers e e v e nt ( A E) is d efi n e d as a n y u nt o w ar d m e dic al occ urr e nc e i n a s u bj ect a d mi nist er e d 
a m e dici n al pr o d uct a n d w hic h d o es n ot n ec ess a ril y h a v e t o h a v e a c a us al r el ati o ns hi p wit h t his 
tr e at m e nt.  A n  a d v ers e  e v e nt  c a n  t h er ef or e  b e  a n y  u nf a v or a bl e  a n d  u ni nt e n d e d  si g n  (f or  
ex a m pl e, a n a b n or m al l a b or at or y fi n di n g), s y m pt o m, or dis e as e t e m p or ally ass oci at e d wit h t h e 
us e of a m e dici n al pr o d uct,  w h et h er or n ot c o nsi d er e d r el at e d t o t his m e dici n al pr o d uct.  
 
A s eri o us a d v ers e e v e nt ( S A E) is a n a d v ers e e v e nt t h at r es ults i n a n y of t h e f oll o wi n g o utc o m es:  
 
•  d e at h  
•  lif e-t hr e at e ni n g  e v e nt  (i. e.,  t h e  s u bj ect  w as,  i n  t h e  o pi [INVESTIGATOR_9384] o n  of  t h e  i n v esti g at or,  at  
i m m e di at e ris k of d e at h fr o m t h e e v e nt as it occ urr e d.  It d o es n ot i ncl u d e a n e v e nt t h at, 
h a d it occ urr e d i n a m or e s e v er e f or m, mi g ht h a v e c a us e d d e at h)  
•  r e q uir es i n-s u bj ect h os pit aliz ati o n or pr ol o n gs h os pit aliz ati o n 
•  a p ersist e nt or si g nific a nt dis a bilit y/i nc a p acit y or s u bst a nti al disr u pti o n of t h e a bilit y t o 
c o n d uct n or m al lif e f u ncti o ns 
•  c o n g e nit al a n o m al y/ birt h d ef ect 
•  ot h er a d v ers e e v e nts t h at m a y b e c o nsi d er e d s eri o us w h e n, b as e d u p o n a p pr o pri at e 
m e dic al j u d g m e nt, t h e y m a y j e o p ar diz e t h e s u bj ect or s u b j ect or m a y r e q uir e m e dic al or 
s ur gic al i nt er v e nti o n t o pr e v e nt o n e of t h e pr e vi o usl y list e d o utc o m es. 
 
I m m e di at el y R e p ort a bl e A d v ers e E v e nts (I R A E): A n y s eri o us A E or a n y A E t h at n ec essit at es 
disc o nti n u ati o n of st u d y m e dic ati o n, i ncl u di n g pr e g n a ncy.  
 
U n ex p ect e d A d v ers e E v e nt : A n u n ex p ect e d e v e nt is a n y a d v ers e dr u g ex p eri e nc e, t h e s p ecificit y 
or s e v erit y of w hic h is n ot c o nsist e nt wit h t h e c urr e nt a p pr o v e d pr o d uct l a b eli n g ( p ac k a g e 
i ns ert) f or t h e st u d y m e dic ati o n, or as d escri b e d i n t h e cli nic al pr ot oc ol a n d c o ns e nt m at eri als.    
 
I nt e nsit y of A d v ers e E v e nts: T h e m axi m u m i nt e nsit y of a n A E d uri n g a d ay s h o ul d b e r ec or d e d 
o n t h e C R F. If t h e i nt e nsit y of a n A E c h a n g es ov er a n u m b er of d a ys, t h e n s e p ar at e e ntri es 
s h o ul d b e m a d e h a vi n g disti nct o ns et d at es f or t h e c h a n g es i n s e v erit y. 
 
Mil d - A Es ar e us u all y tr a nsi e nt, r e q uiri n g n o s p eci al tr e at m e nt, a n d d o n ot i nt erf er e 
wit h s u bj ect’s d ail y acti viti es.  
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29296]’s us u al d ail y acti vit y a n d tr a diti o n all y r e q uir e s yst e mic 
dr u g t h er a p y or ot h er tr e at m e nt.  
 
 
C a us al R el ati o ns hi p t o St u d y M e dic ati o n:   
T h e f oll o wi n g crit eri a s h o ul d b e us e d i n ass essi n g t h e a p p ar e nt c a us al r el ati o ns hi p of a n A E t o 
st u d y m e dic ati o n.  
 
D efi nit el y - T h e A E:  
• f oll o ws a r e as o n a bl e t e m p or al s e q u e nc e fr o m st u d y m e dic ati o n a d mi nistr ati o n 
• a b at es u p o n disc o nti n u ati o n of t h e st u d y m e dic ati o n ( d ec h all e n g e)  
• is c o nfir m e d b y r e a p p e ar a nc e of t h e r e acti o n o n r e p e at ex p os ur e 
 
Pr o b a bl y - T h e A E:  
• f oll o ws a r e as o n a bl e t e m p or al s e q u e nc e fr o m st u d y m e dic ati o n a d mi nistr ati o n 
• a b at es u p o n disc o nti n u ati o n of t h e st u d y m e dic ati o n ( d ec h all e n g e).  
• c a n n ot b e r e as o n a bl y ex pl ai n e d b y t h e k n o w n c h ar act eristics of t h e s u bj ect’s st at e.  
 
P ossi bl e - T h e A E:  
• f oll o ws a r e as o n a bl e t e m p or al s e q u e nc e fr o m st u d y m e dic ati o n a d mi nistr ati o n 
• b ut t h at c o ul d r e a dil y b e pr o d uc e d b y a n u m b er of ot h er f act ors . 
 
U nli k el y - T h e A E:  
• f oll o ws a r e as o n a bl e t e m p or al s e q u e nc e fr o m st u d y m e dic ati o n a d mi nistr ati o n. 
• c o ul d h a v e b e e n pr o d uc e d b y eit h er t h e s u bj ect’s cli nic al st at e or b y st u d y m e dic ati o n 
a d mi nistr ati o n.  
 
N ot r el at e d - T h e A E:  
• d o es  n ot  h a v e  a  r e as o n a bl e  t e m p or al  ass oci ati o n  wit h  t h e  a d mi nistr ati o n  of  st u d y  
m e dic ati o n  
• h as s o m e ot h er o b vi o us ex pl a n ati o n f or t h e e v e nt  
 
7. [ADDRESS_29297] s h o ul d b e as k e d a n o n-s p ecific q u esti o n 
( e. g., “ H o w h a v e y o u b e e n f e eli n g si nc e y o ur l ast visit ?”) t o ass ess w h et h er a n y A E h as b e e n 
ex p eri e nc e d si nc e t h e l ast visit.  All a d v ers e e v e nts ( as d efi n e d i n S ecti o n 7. 2 ), eit h er o bs er v e d 
b y t h e I n v esti g at or or o n e of his/ h er m e dic al c oll a b or at ors, or r e p ort e d b y t h e p artici p a nt 
s p o nt a n e o usl y, or i n r es p o ns e t o dir ect q u esti o ni n g, will b e r e p ort e d a n d d oc u m e nt e d i n t h e 
Pr ot oc ol: P R G -N Y -[ADDRESS_29298] e d t o:  
 
: 
 
 
 
 
  
 
 
 
  
 
 
S p o ns or c o nt act d et ails:  
 
 
 
 
  
 
 
7. 3. [ADDRESS_29299] e d  or  w h e n  p erti n e nt  i nf or m ati o n  b ec o m es  
a v ail a bl e.  
Pr ot oc ol: P R G -N Y -[ADDRESS_29300] u d y c e nt er’s I R B.  T h e Pri nci p al I n v esti g at or m ust r et ai n a c o p y of 
s uc h r e p orts as s u b mitt e d t o t h eir I R B i n t h e sit e’s st u d y R e g ul at or y Bi n d er. 
7. 4  S A E & A Es R e q uiri n g Disc o nti n u ati o n of St u d y Dr u g, i ncl u di n g Pr e g n a nci es  
A N Y S A E, W HI C H O C C U R S A F T E R A S U BJ E C T H A S E N T E R E D T H E S T U D Y, W H E T H E R O R N O T 
R EL A T E D T O S T U D Y M E DI C A TI O N, M U S T B E R E P O R T E D T O   I M M E DI A T EL Y ( WI T HI N 2 4 
H O U R S) VI A T EL E P H O N E O R F A C SI MIL E. I F I NI TI ALL Y R E P O R T E D VI A T EL E P H O N E, T HI S M U S T B E 
F OLL O W E D- U P B Y A F A C SI MIL E O F T H E W RI T T E N S A E R E P O R T WI T HI N [ADDRESS_29301] u d y  m e dic ati o n  (i ncl u di n g  l a b or at or y  
a b n or m aliti es)  s h o ul d  b e  r e p ort e d  t o  t h e  s p o ns or  i m m e di at el y  a n d  wit hi n  [ADDRESS_29302] u d y  p artici p ati o n,  t h e  Pri nci p al  I n v esti g at or  or  d esi g n e e  will  
r e p ort t h e pr e g n a ncy i m m e di at el y b y p h o n e a n d/ or b y f axi n g a c o m pl et e d Pr e g n a ncy R e p ort t o 
 wit hi n o n e w or ki n g d a y of b ei n g n otifi e d of t h e pr e g n a ncy r e p ort. 
 
T h e r e p ort will i ncl u d e t h e f oll o wi n g el e m e nts:  
•  P artici p a nt ( m ot h er’s) c o d e d st u d y i d e ntifi er;  
•  D at e of p artici p a nt’s l ast m e nstr u al p eri o d;  
•  T ot al acc u m ul at e d d os e of st u d y tr e at m e nt a d mi nist er e d t o d at e;  
•  D at e of st u d y m e dic ati o n a d mi nistr ati o n.  
 
T h e i n v esti g at or will f oll o w t h e s u bj ect u ntil c o m pl eti o n of t h e pr e g n a ncy a n d m ust ass ess t h e 
o utc o m e i n t h e s h ort est p ossi bl e ti m e b ut n ot m or e t h a n [ADDRESS_29303] f or w ar d a 
f oll o w-u p Pr e g n a ncy R e p ort wit h a n y r el e v a nt i nf or m ati o n o n t h e pr es e nt c o n diti o n of t h e f et us 
t o t h e  , i ncl u di n g: 
•  M ot h er’s c o d e d st u d y i d e ntifi er(s);  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 3 8  of 5 1 •  G est a ti o n al a g e at d eli v er y, misc arri a g e or a b orti o n; 
•  Birt h w ei g ht, g e n d er, l e n gt h a n d h e a d circ u mf er e nc e, if a v ail a bl e;  
•  A p g ar sc or es r ec or d e d aft er birt h, if a v ail a bl e;  
•  A n y a b n or m aliti es.  
 
If t h e o utc o m e of t h e pr e g n a ncy m e ets t h e crit eri a f or i m m e di at e cl assific ati o n of a n S A E ( e. g., 
s p o nt a n e o us or t h er a p e utic a b orti o n [ a n y c o n g e nit al a n o m al y d et ect e d i n a n a b ort e d f et us is t o 
b e d oc u m e nt e d], still birt h, n e o n at al d e at h, or c o n g e nit al a n o m al y), t h e i n v esti g at or will r e p ort 
t h e e v e nt b y p h o n e a n d b y f axi n g a c o m pl et e d S A E r e p ort f or m t o   wit hi n o n e w or ki n g 
d a y of b ei n g n otifi e d of t h e pr e g n a ncy r e p ort.  
 
If t h e tri al is c o m pl et e d b ef or e t h e o utc o m e of t h e pr e g n a ncy is k n o w n,   will ass u m e t h e 
r es p o nsi bilit y f or f oll o wi n g u p o n t h e pr e g n a ncy.     will c o nt act t h e I n vesti g at or or St u d y 
c o or di n at or o n or ar o u n d t h e p ot e nti al ex p ect e d d at e of d eli v er y t o f oll o w -u p o n t h e o utc o m e 
of pr e g n a ncy a n d will als o c h ec k o n t h e st at us of t h e i nf a nt [ADDRESS_29304] ass ess m e nt visit ( or t h e e arl y t er mi n ati o n visit) 
m ust b e r ec or d e d o n t h e A E C R F wit h t h e st at us of t h e A E n ot e d.  All e v e nts t h at ar e o n g oi n g at 
t his ti m e will b e r ec or d e d as o n g oi n g o n t h e C R F. 
 
7. 5. [ADDRESS_29305] ass ess m e nt visit ( or t h e e arl y t er mi n ati o n 
visit) m ust b e r ec or d e d o n t h e A E C R F p a g e a n d r e p ort e d t o t h e M e dic al M o nit or acc or di n g t o 
t h e pr oc e d ur es o utli n e d a b o v e.  S u bj ects wit h u nr es ol v e d pr e vi o usl y r e port e d s eri o us a d v ers e 
e v e nts, or a n y n e w s eri o us a d v ers e e v e nts i d e ntifi e d o n t h e l ast ass ess m e nt visit, s h o ul d b e 
f oll o w e d b y t h e i n v esti g at or u ntil t h e e v e nts ar e r es ol v e d, or t h e s u bj ect is l ost t o f oll o w-u p.  
R es ol uti o n m e a ns t h e s u bj ect h as r et ur n e d t o t h e b as eli n e st at e of h e alt h, or t h e i n v esti g at or 
d o es n ot ex p ect a n y f urt h er i m pr o v e m e nt or w ors e ni n g of t h e a d v ers e e v e nt.  T h e i n v esti g at or 
s h o ul d c o nti n u e t o r e p ort a n y si g nific a nt f oll o w-u p i nf or m ati o n t o P erri g o u p t o t h e p oi nt t h at 
t h e e v e nt h as r es ol v e d.  A n y s eri o us a d v ers e e v e nt r e p ort e d b y t h e s u bj ect t o t h e i n v esti g at or 
t h at occ urs aft er t h e l ast ass ess m e nt, a n d is d et er mi n e d b y t h e i n v esti g at or t o b e r e as o n a bl y 
ass oci at e d wit h t h e us e of t h e st u d y m e dic ati o n, s h o ul d b e r e p ort e d t o P erri g o a n d  f oll o we d -u p  
u p as n ot e d a b o v e.   
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29306] a n ( S A P) will b e pr e p ar e d s e p ar at el y fr o m t his pr ot oc ol a n d it will 
d escri b e  st atistic al m et h o ds, m o d els, h y p ot h es es a n d s u bj ect p o p ul ati o ns t o b e a n al yz e d.  T h e 
S A P will b e c o m pl et e d a n d a p pr o v e d b ef or e l oc ki n g t h e d at a b as e a n d u n bli n di n g t h e st u d y a n d 
will s er v e as d oc u m e nt ati o n of t h e pl a n n e d st atistic al m et h o ds  a n d will s erv e as a c o m p a ni o n t o 
t h e pr ot oc ol a n d t h e d e f act o  d oc u m e nt ati o n of t h e pr o p os e d st atistic al e v al u ati o n.  T h e S A P 
will b e c o m pl et e d a n d fi n aliz e d pri or t o br e a ki n g t h e bli n d.  
 
8. 1. 1  A n al ysis P o p ul ati o ns  
I nt e nt-t o-tr e at (I T T) p o p ul ati o n:  a n y s u bj ect w h o: ( a) w as r a n d o miz e d i nt o t h e st u d y a n d ( b) 
a p pli e d at l e ast [ADDRESS_29307] u d y m e dic ati o n i ntr a v a gi n all y.  
  
M o difi e d I nt e nt-t o-tr e at (m I T T) p o p ul ati o n: a n y s u bj ect w h o ( a) w as r a n d o miz e d i n t h e st u d y 
( b) a p pli e d at l e ast [ADDRESS_29308] u d y m e dic ati o n i ntr a v a gi n all y, (c) c o m pl et e d at l e ast 
o n e p ost r a n d o miz ati o n ass ess m e nt , a n d ( d) m et eli gi bilit y crit eri a.  
 
P er Pr ot oc ol ( P P) p o p ul ati o n ; a n y s u bj ect w h o ( a) w as r a n d o miz e d  i n t h e st ud y a n d m et all 
i ncl usi o n/ excl usi o n crit eri a, ( b) h a d n ot t a k e n a n y c o nc o mit a nt m e dic ati o ns pr o hi bit e d b y t h e 
pr ot oc ol or h a d a n y ot h er si g nific a nt pr ot oc ol vi ol ati o ns; (c)  r et ur n e d f or Visit 3/ E n d of St u d y 
wit hi n t h e d esi g n at e d visit wi n d o w  wit h  d at a o n t h e pri m ar y effic acy e n d p oi nt a n d; d) 
h a d a st u d y m e dic ati o n a p plic ati o n c o m pli a nc e r at e  
O R w as disc o nti n u e d fr o m t h e st u d y d u e t o l ac k of tr e at m e nt eff ect  
   
 
 
 
 
 
 
 
 
 
 
. 
 
8. 1. [ADDRESS_29309] e d.  R es ulti n g p -v al u es ≤  0. [ADDRESS_29310] atistic all y 
Pr ot oc ol: P R G -N Y -[ADDRESS_29311] a n n e d.  S A S s oft w ar e  V ersi o n 9. 1. 3  will b e us e d f or all d at a a n al ys es a n d 
t a b ul ati o ns. 
 
T h e tr e at m e nt r es p o ns e will b e s u m m ariz e d b y tr e at m e nt gr o u p f or Visit 3/ E n d of St u d y 
e v al u ati o n.  T h e pri m ar y effic acy e n d p oi nt will b e t h e pr o p orti o n of s u bj ects t h at ar e i d e ntifi e d 
as r es p o n d ers at V isit 3/ E n d of St u d y.  A r es p o n d er is d efi n e d as a s u bj ect wit h at l e ast a 2 5 % 
r e d ucti o n fr o m b as eli n e i n t h e s u m of % ( p erc e nt) b as al/ p ar a b as al + % ( p erc e nt) i nt er m e di at e 
c ells o n v a gi n al cyt ol o g y A N D v a gi n al p H < 5. 0 wit h a c h a n g e fr o m Visit 1/ Scr e e ni n g  va gi n al p H 
of at l e ast 0. 5.  
 
T h e s ec o n d ar y e n d p oi nt will b e t h e pr o p orti o n of s u bj ects wit h tr e at m e nt s ucc ess b as e d o n t h e 
i m pr o v e m e nt (c h a n g e fr o m b as eli n e) of t h e m ost b ot h ers o m e s y m pt o m of V V A at Visit 3/ E n d 
of st u d y. Tr e at m e nt s ucc ess is d efi n e d as a c h a n g e fr o m b as eli n e w hic h will r es ult i n a sc or e of 0 
( n o n e) or 1 ( mil d) at Visit [ADDRESS_29312] e Siz e C o nsi d er ati o ns  
 
 
 
 
 
 
   
 
 
 
  
8. 1. 4  Effic ac y M e as ur es a n d A n al ysis  
Cli nic al e n d p oi nts  
Pr ot oc ol: P R G -N Y -[ADDRESS_29313] a 2 5 % r e d ucti o n fr o m b as eli n e i n t h e s u m of % b a s al/ p ar a b as al + % 
i nt er m e di at e  c ells  o n  v a gi n al  cyt ol o g y  A N D  v a gi n al  p H  <  5. 0  wit h  a  c h a n g e  fr o m  Visit 
1/ Scr e e ni n g/ B as eli n e  v a gi n al p H of at l e ast 0. 5.  
E q ui v al e nt effic acy  
 
T h e cli nic al e q ui v al e nc e of t h e t est a n d r ef er e nc e tr e at m e nts will b e b as e d o n t h e  pr o p orti o n of 
s u bj ects i d e ntifi e d as r es p o n d ers at Visit 3/ E n d of St u d y ( D a y 8).  T h e 9 0 % W al d’s c o nfi d e nc e 
i nt er v al, usi n g Y at es’ c o nti n uit y c orr ecti o n, will b e c o nstr uct e d o n t h e diff er e nc e b et w e e n t h e 
t est a n d r ef er e nc e r es p o n d er pr o p orti o ns.  If t h e co nfi d e nc e  i nt er v al is e ntir el y c o nt ai n e d 
wit hi n t h e i nt er v al – 2 0 % t o + 2 0 %, t h e n t h e t est pr o d uct will b e c o nsi d er e d t o b e cli nic all y 
e q ui v al e nt t o t h e r ef er e nc e pr o d uct.  T h e a n al ysis will b e c o n d uct e d o n b ot h t h e P er -Pr ot oc ol 
( P P) p o p ul ati o n a n d t h e m o dif i e d I nt e nt-T o -Tr e at ( m I T T) p o p ul ati o n.  T h e e v al u ati o n i n t h e P P 
p o p ul ati o n will b e c o nsi d er e d d efi niti v e, wit h t h at i n t h e m I T T p o p ul ati o n as s u p p orti v e. 
 
S u p eri orit y  
 
E ac h  acti v e  tr e at m e nt’s  r es p o n d er  pr o p orti o n  will  b e  c o m p ar e d  t o  t h at  of  t h e  V e hicl e , 
in d e p e n d e ntl y ( T est vs. V e hicl e, R ef er e nc e vs. V e hicl e ), usi n g a t w o-si d e d, α  = 0. [ADDRESS_29314].  If e ac h acti v e tr e at m e nt’s r es p o n d er pr o p orti o n at Visit 3/ E n d of St u d y will b e  
st atistic all y gr e at er t h a n t h at of t h e V e hicl e  ( p< 0. 0 5) , t h e n s u p eri orit y will b e c o nsi d er e d t o 
h a v e b e e n d e m o nstr at e d. S u p eri orit y a n al ys es will b e c o n d uct e d o n b ot h t h e P P a n d t h e m I T T 
p o p ul ati o n s.  T h e a n al ys es i n t h e m I T T p o p ul ati o n will b e c o nsi d er e d pri m ar y, whil e  t h os e i n t h e 
P P as s u p p orti v e.  
 
I n t h e m I T T p o p ul ati o n, a L ast-O bs er v ati o n -C arri e d -F or w ar d a p pr o ac h will b e us e d t o i m p ut e 
missi n g effic acy r es ults.  F or s u bj ects w h o disc o nti n u e d u e t o tr e at m e nt f ail ur e, t h e y will b e 
i ncl u d e d i n t h e P P p o p ul ati o n as n o n-r es p o n d ers f or t h e pri m ar y a n al ys es.  N o f or m al st atistic al 
a n al ys es ar e pl a n n e d t o e v al u at e t h e c o nsist e ncy of effic acy r es ults acr oss t h e m ulti pl e c e nt ers 
f or t h e pri m ar y effic acy v ari a bl e.  T h es e r es ults, h o w e v er, will b e t a b ul at e d a n d, if a c e nt er’s 
r es p o ns e is o b vi o usl y i nc o nsist e nt wit h t h os e of t h e ot h er c e nt ers, t his will b e ex pl or e d a n d 
a d dr ess e d i n t h e fi n al st u d y r e p ort.  
 
S ec o n d ar y A n al ys es  
 
T h e s ec o n d ar y e n d p oi nt will b e t h e pr o p orti o n of s u bj ects wit h tr e at m e nt s ucc ess b as e d o n t h e 
i m pr o v e m e nt (c h a n g e fr o m b as eli n e) of t h e M ost B ot h ers o m e S y m pt o m of V V A at Visit 3/ E n d 
of St u d y.  Tr e at m e nt s ucc ess is d efi n e d as a c h a n g e fr o m b as eli n e w hic h will r es ult i n a sc or e of 
0 ( n o n e) or 1 ( mil d) at Visit [ADDRESS_29315] 
B ot h ers o m e S y m pt o m is v a gi n al bl e e di n g ass oci at e d wit h s ex u al acti vit y t h e n tr e at m e nt 
s ucc ess will b e a bs e nc e of v a gi n al bl e e di n g ass oci at e d wit h s ex u al acti vit y as r e p ort e d at t h e 
Pr ot oc ol: P R G -N Y -[ADDRESS_29316] b ot h ers o m e s y m pt o m of V V A at 
Visit 3/ E n d of st u d y. T h e s e v erit y of M ost B ot h ers o m e S y m pt o m of V V A will b e ass ess e d b as e d 
o n t h e sc ori n g sc al e: 0 ( n o n e ), 1 ( mil d ), 2( m o d er at e) a n d 3 (s e v er e) as d efi n e d i n S ecti o n 5. 5.  
 
8. 1. 5  S af et y a n d A d v ers e E v e nts A n al ysis  
A Es will b e c o d e d usi n g t h e M e dic al Dicti o n ar y f or R e g ul at or y Acti viti es ( M e d D R A), V ersi o n  [ADDRESS_29317] w h o r e p ort e d a n y a d v ers e e v e nts usi n g C hi -
S q u ar e or Fis h er’s  ex act t est if a p pr o pri at e.    
 
S A Es will b e disc uss e d wit hi n t h e cli nic al st u d y r e p ort.  D at a c oll ect e d p ert ai ni n g t o S A Es will b e 
pr es e nt e d i n d at a listi n gs.  
 
C o nc o mit a nt m e dic ati o ns will b e cl assifi e d acc or di n g t o t h e W orl d H e alt h Or g a niz ati o n ( W H O) 
Dr u g  Dicti o n ar y, t h e S e pt e m b er [ADDRESS_29318] a w al  fr o m  c urr e nt  m e dic ati o n(s).   W h e n  t his  is  d o n e  i n  
a ntici p ati o n of, or i n pr e p ar ati o n f or, t h e r es e arc h, it is  c o nsi d er e d t o b e p art of t h e r es e arc h. 
 
T h e st u d y m ust b e a p pr o v e d i n writi n g b y a n a p pr o pri at e I R B as d efi n e d b y F D A r e g ul ati o ns.  A 
c o p y of t h e L ett er of A p pr o v al fr o m t h e I R B, w hic h als o c o nt ai ns s p ecific i d e ntific ati o n of t h e 
d oc u m e nts a p pr o v e d, m ust b e r ec ei v e d b y P erri g o, pri or t o st u d y c o m m e nc e m e nt.  
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29319] a n n u all y as r e q uir e d b y t h e sit e’s 
I R B, as w ell as n otific ati o n of c o m pl eti o n of t h e st u d y a n d a fi n al r e p ort wit hi n t hr e e m o nt hs of 
st u d y c o m pl eti o n or t er mi n ati o n.  A c o p y of all r e p orts s u b mitt e d t o t h e I R B m ust b e s e nt t o 
P erri g o  
 
T h e i n v esti g at or(s) h as b ot h et hic al a n d l e g al r es p o nsi bilit y t o e ns ur e t h at e ac h s u bj ect b ei n g 
c o nsi d er e d f or i ncl usi o n i n t his st u d y is gi v e n a f ull ex pl a n ati o n of t h e pr ot oc ol.  T his s h all b e 
d oc u m e nt e d  o n  a  writt e n  i nf or m e d  c o ns e nt  f or m,  w hic h  s h all  b e  a p pr o v e d  b y  t h e  s a m e  
I nstit uti o n al  R e vi e w  B o ar d  (I R B)  r es p o nsi bl e  f or  a p pr o v al  of  t his  pr ot oc ol.  E ac h  i nf or m e d  
c o ns e nt f or m s h all i ncl u d e t h e el e m e nts r e q uir e d  b y F D A r e g ul ati o ns i n [ADDRESS_29320] ai n e d  b y  t h e  i n v esti g at ors  ( or  a  q u alifi e d  d esi g n e e)  a n d  it  is  f elt  t h at  t h e  s u bj ect  
u n d erst a n ds t h e i m plic ati o ns of p artici p ati n g, t h e I R B -a p pr o v e d writt e n i nf or m e d c o ns e nt f or m 
s h all b e si g n e d b y t h e s u bj ect  a n d t h e p ers o n o bt ai ni n g c o ns e nt (i n v esti g at or or d esi g n e e).  T h e 
s u bj ect s h all b e gi v e n a c o p y of t h e si g n e d i nf or m e d c o ns e nt/ ass e nt f or m a n d t h e i n v esti g at or 
s h all k e e p t h e ori gi n al o n fil e. 
 
If t h e s u bj ect f ails t o m e et t h e i ncl usi o n/ excl usi o n crit eri a at t h e c o ncl usi o n of t h e scr e e ni n g 
p h as e, t h e s u bj ect will b e wit h dr a w n fr o m scr e e ni n g.  I n t h e e v e nt t h at t h e s u bj ect is r e -
scr e e n e d f or st u d y p artici p ati o n, a n e w i nf or m e d c o ns e nt/ ass e nt f or m m ust b e si g n e d. 
 
9. [ADDRESS_29321]’s pri v acy a n d, t h er ef or e, all s u bj ect 
d at a will b e i d e ntifi e d o nl y b y a s u bj ect i d e ntific ati o n n u m b er a n d s u bj ect i niti als. H o w e v er, i n 
c o m pli a nc e wit h f e d er al g ui d eli n es r e g ar di n g t h e m o nit ori n g of  cli nic al st u di es a n d i n f ulfill m e nt 
of his/ h er o bli g ati o ns t o P erri g o, it is r e q uir e d t h at t h e i n v esti g at or p er mit t h e st u d y m o nit or, 
a n y S p o ns or a ut h oriz e d r e pr es e nt ati v e, a n d/ or F D A r e pr es e nt ati v e t o r e vi e w t h at p orti o n of t h e 
s u bj ect’s m e dic al r ec or d th at is dir ectl y r el at e d t o t h e st u d y.  T his s h all i ncl u d e all st u d y r el e v a nt 
d oc u m e nt ati o n i ncl u di n g s u bj ect m e dic al hist ori es t o v erif y eli gi bilit y, l a b or at or y t est r es ult 
r e p orts  t o  v erif y  tr a nscri pti o n  acc ur acy,  a d missi o n/ disc h ar g e  s u m m ari es  f or  h os pit al  st a ys  
occ urri n g w hil e t h e s u bj ect is e nr oll e d i n t h e st u d y a n d a ut o ps y r e p orts f or d e at hs occ urri n g 
d uri n g t h e st u d y.  
 
As p art of t h e r e q uir e d c o nt e nt of i nf or m e d c o ns e nt, t h e s u bj ect m ust b e i nf or m e d t h at his/ h er 
m e dic al  c h art  m a y  b e  r e vi e w e d  b y  P erri g o  or  t h eir  a ut h oriz e d  r e pr es e nt ati v e,  or  a  
r e pr es e nt ati v e of t h e F D A.  S h o ul d acc ess t o t h e m e dic al r ec or d r e q uir e a s e p ar at e w ai v er or 
a ut h oriz ati o n, it is t h e i nv esti g at or’s r es p o nsi bility t o o bt ai n s uc h p er missi o n fr o m t h e s u bj ect i n 
writi n g b ef or e t h e s u bj ect is e nt er e d i nt o t h e st u dy.  
 
Pr ot oc ol: P R G -N Y -[ADDRESS_29322]'s  c o nfi d e nti alit y,  t h e  d at a  c oll ect e d  will  b e  a v ail a bl e  o nl y  t o  t h e  
i n v esti g at ors of t h e st u d y, t h eir s u p p ort st aff, P erri g o or t h eir a ut h oriz e d r e pr es e nt ati v e a n d 
p ossi bl y t h e F D A.  
 
All r e p orts a n d c o m m u nic ati o ns r el ati n g t o t h e s u bj ect i n t h e st u d y will i d e ntif y e ac h s u bj ect 
o nl y b y t h e s u bj ect’s i niti als a n d b y t h e s u bj ect n u m b er. T h e i n v esti g at or a gr e es t o f ur nis h 
P erri g o wit h c o m pl et e s u bj ect i d e ntific ati o n, if n ec ess ar y o n a c o nfi d e nti al f oll o w- u p f or m, 
w hic h will b e us e d f or t h e p ur p os e of a l o n g -t er m f oll o w-u p, if n e e d e d.  T his will b e tr e at e d wit h 
strict a d h er e nc e t o pr of essi o n al st a n d ar ds of c o nfi d e nti alit y a n d will b e fil e d at P erri g o u n d er 
a d e q u at e s ec urit y a n d r estrict e d acc essi bilit y  
 
[ADDRESS_29323] u d y c e nt er(s), m ust b e h a n dl e d as a pr ot o c ol 
a m e n d m e nt. A n y a m e n d m e nt t o t h e pr ot oc ol t h at a p p e ars i n dic at e d as t h e st u d y pr o gr ess es 
will b e f ull y disc uss e d b et w e e n   a n d P erri g o. If a gr e e m e nt is r e ac h e d r e g ar di n g t h e 
n e e d f or a n a m e n d m e nt, t h e a m e n d m e nt will b e writt e n b y P erri g o. T h e w ritt e n a m e n d m e nt 
m ust b e s u b mitt e d t o t h e c h air m a n of t h e I R B i d e ntifi e d wit h t his r es p o nsi bilit y.  Exc e pt f or 
‘ a d mi nistr ati v e a m e n d m e nts’, i n v esti g at ors m ust a w ait I R B a p pr o v al of pr ot oc ol a m e n d m e nts 
b ef or e i m pl e m e nti n g t h e c h a n g e(s). A d mi nistr ati v e a m e n d m e nts ar e d efi n e d t o h a v e n o eff ect 
o n  t h e  s af et y  of  t h e  r es e arc h  s u bj ects,  sc o p e  of  t h e  i n v esti g ati o n,  or  q u alit y  of  t h e  tri al.   
H o w e v er, a pr ot oc ol c h a n g e i nt e n d e d t o eli mi n at e a n a p p ar e nt i m m e di at e h az ar d t o s u bj ects 
s h o ul d b e i m pl e m e nt e d i m m e di at el y, a n d t h e I R B n otifi e d wit hi n fi v e d ays.  P erri g o will s u b mit 
pr ot oc ol a m e n d m e nts t o t h e F D A or ot h er r e g ul at or y a g e nci es.  
 
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 4 5  of 5 1 W h e n, i n t h e j u d g m e nt of t h e r e vi e wi n g I R B, t h e i n v esti g at ors a n d/ or P erri g o, t h e a m e n d m e nt 
t o t h e pr ot oc ol s u bst a nti all y alt ers t h e stu d y d esi g n a n d/ or i ncr e as es t h e p ot e nti al ris k t o t h e 
s u bj ect,  t h e  c urr e ntl y  a p pr o v e d  writt e n  i nf or m e d  c o ns e nt  f or m  will  r e q uir e  si mil ar  
m o dific ati o n.  I n s uc h c as es, r e p e at i nf or m e d c o ns e nt will b e o bt ai n e d fr o m s u bj ects e nr oll e d i n 
t h e st u d y b ef or e ex p ecti n g c o nti n u e d p artici p ati o n. 
 
[ADDRESS_29324] u d y  will  b e  e nt er e d  o nt o  c as e  r e p ort  f or ms  ( C R Fs),  v erifi e d  b y 
m o nit ori n g, a n d s u b mitt e d f or st atistic al e v al u ati o n as d escri b e d b el o w.  C h ec ks will b e r u n o n 
t h e d at a a n d q u eri es iss u e d as n e e d e d. O nc e all d at a is cl e a n e d, f ull q u alit y c o ntr ol v erific ati o n 
will b e d o n e pri or t o br e a ki n g t h e bli n d. Aft er all d at a ar e c orr ectl y e nt er e d, t h e d at a b as e will 
b e l oc k e d a n d s u b mitt e d f or a p pr o pri at e Q u ality Ass ur a nc e v erific ati o ns b ef or e t h e tr e at m e nt 
assi g n m e nt c o d e is br o k e n.  All d at a c oll ect e d i n t h e C R Fs will b e d oc u m e nt e d i n s u bj ect d at a 
listi n gs a n d s u m m ariz e d i n t a bl es, as a p pr o pri at e. 
 
D uri n g e ac h s u bj ect’s visit t o t h e cli nic, a d esi g n e e p artici p ati n g i n t h e st u dy will r ec or d pr o gr ess 
n ot es t o d oc u m e nt all si g nific a nt o bs er v ati o ns.  At a mi ni m u m, t h es e n ot es will c o nt ai n:  
 
a)  D oc u m e nt ati o n of t h e i nf or m e d c o ns e nt pr oc ess;  
b)  T h e d at e of t h e visit a n d t h e c orr es p o n di n g Visit or W e e k i n t h e st u d y sc h e d ul e;  
c) G e n er al s u b j ect st at us r e m ar ks, i ncl u di n g a n y si g nific a nt m e dic al fi n di n gs.  T h e s e v erit y, 
fr e q u e ncy, a n d d ur ati o n of a n y a d v ers e e v e nts a n d t h e i n v esti g at or's ass ess m e nt of 
r el ati o ns hi p t o st u d y m e dic ati o n m ust als o b e r ec or d e d. 
d)  A n y c h a n g es i n c o nc o mit a nt m e dic ati o n s or d os a g es; 
e)  A g e n er al r ef er e nc e t o t h e pr oc e d ur es c o m pl et e d; a n d  
f) T h e si g n at ur e ( or i niti als) a n d d at e of all cli nici a ns w h o m a d e a n e ntr y i n t h e pr o gr ess 
n ot es.  
 
I n a d diti o n, a n y c o nt act wit h t h e s u bj ect vi a t el e p h o n e or ot h er m e a ns t h at pr o vi d es si g nific a nt 
cli nic al i nf or m ati o n will als o b e d oc u m e nt e d i n t h e pr o gr ess n ot es as d escri b e d a b o v e.  
 
A n y c h a n g es t o i nf or m ati o n i n t h e st u d y pr o gr ess n ot es a n d ot h er s o urc e d oc u m e nts, will b e 
e nt er e d  i n  bl ac k  i n k , i niti al e d a n d d at e d b y  t h e  a ut h oriz e d  p ers o n  m a ki n g  t h e  
c orr ecti o n/ a d diti o n.  C h a n g es will b e m a d e b y striki n g a si n gl e li n e t hr o u g h err o n e o us d at a, a n d 
cl e arl y e nt eri n g t h e c orr ect d at a.  ( e. g., wr o n g d at a  ri g ht d at a).  E ntri es m a y n ot b e er as e d or 
m as k e d wit h w hit e -o ut fl ui d.  If t h e r e as o n f or t h e c h a n g e is n ot a p p ar e nt, a bri ef ex pl a n ati o n 
f or t h e c h a n g e will b e writt e n a dj ac e nt t o t h e c h a n g e b y t h e cli nici a n. 
 
F or  tr a ns missi o n  t o  P erri g o,  i nf or m ati o n  fr o m  t h e  st u d y  pr o gr ess  n ot es  a n d  ot h er  s o urc e  
d oc u m e nts will b e pr o m ptl y e nt er e d i nt o t h e d at a b as e.  T h e d at a b as e  als o c o nt ai ns a c o m pl et e 
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 4 6  of 5 1 a u dit tr ail t o c a pt ur e all r e g ul at or y c o m p o n e nts of d at a c orr ecti o ns ( e. g. i niti al e ntr y, n e w v al u e, 
i niti als a n d d at e of t h e c h a n g e). 
 
[ADDRESS_29325] u d y c e nt er fil e is m ai nt ai n e d i n 
acc or d a nc e wit h S ecti o n 8 of t h e I nt er n ati o n al C o nf er e nc e o n H ar m o niz ati o n (I C H) G ui d eli n e f or 
G o o d Cli nic al Pr actic es ( G C P) . 
 
[ADDRESS_29326] u di es  t o  m ai nt ai n  
d et ail e d cli nic al d at a f or o n e of t h e f oll o wi n g p eri o ds:  
 
a)  A p eri o d of at l e ast t w o y e ars f oll o wi n g t h e d at e o n w hic h a N e w Dr u g A p plic ati o n is 
a p pr o v e d b y t h e F D A;  
b)  A p eri o d of t w o y e ars aft er P erri g o n otifi es t h e i nv esti g at or t h at n o f urt h er a p plic ati o n is 
t o b e fil e d wit h t h e F D A. 
 
T h e i n v esti g at or m ust n ot dis p os e of a n y r ec or ds r el e v a nt t o t his st u dy wit h o ut eit h er ( 1) 
writ t e n p er missi o n fr o m P erri g o or ( 2) pr o vi di n g a n o p p ort u nit y f or P erri g o t o c oll ect s uc h 
r ec or ds.   T h e  i n v esti g at or  s h all  t a k e  r es p o nsi bilit y  f or  m ai nt ai ni n g  a d e q u at e  a n d  acc ur at e  
el ectr o nic or h ar d c o p y s o urc e d oc u m e nts of all o bs er v ati o ns a n d d at a g e n er at e d d uri n g t his 
st u d y,  i ncl u di n g  a n y  d at a  c orr ecti o n f or ms  ( D C Fs)  r ec ei v e d  fr o m  .  S uc h  
d oc u m e nt ati o n is s u bj ect t o i ns p ecti o n b y P erri g o a n d t h e F D A.  
 
[ADDRESS_29327] es a n d F D A r e g ul ati o ns.  All 
m e dic al  r ec or ds  (s o urc e  d oc u m e nts)  of  t h e  s u bj ects  p artici p ati n g  i n  t his  st u d y  m ust  b e  
pr es e nt e d f or r e vi e w  a n d v erific ati o n of C R Fs.  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 4 7  of 5 1 1 2. 2  A u diti n g  
P erri g o  ( or r e pr es e nt ativ e) m a y c o n d uct a u dits at t h e st u d y c e nt er(s).  A u dits will i ncl u d e, b ut 
ar e n ot b e li mit e d t o, dr u g s u p pl y, pr es e nc e of r e q uir e d d oc u m e nts, t h e i nf or m e d c o ns e nt 
pr oc ess, a n d c o m p aris o n of C R F s wit h s o urc e d oc u m e nts.  T h e i n v esti g at or a gr e es t o p artici p at e 
wit h a u dits c o n d uct e d at a r e as o n a bl e ti m e i n a r e as o n a bl e m a n n er.  
 
R e g ul at or y a ut h oriti es w orl d wi d e m a y als o a u dit t h e i n v esti g at or d uri n g or aft er t h e st u d y. T h e 
i n v esti g at or s h o ul d c o nt act P erri g o i m m e di at el y if n otifi e d of s uc h a n a u dit, a n d m ust f ull y 
c o o p er at e wit h t h e a u dits c o n d uct e d at a r e as o n a bl e ti m e i n a r e as o n a bl e m a n n er.  
 
[ADDRESS_29328] u g  A d mi nistr ati o n  ( F D A)  r e g ul ati o ns,  a n y  ot h er  c o u ntri es  r e g ul ati o ns,  a n d  I C H  G C P  
G ui d eli n es.  
 
[ADDRESS_29329] u d y a n d n ot pr e vi o usl y p u blis h e d, 
is c o nsi d er e d c o nfi d e ntial i nf or m ati o n.  T his i nf or m ati o n i ncl u d es, b ut is n ot li mit e d t o, d at a, 
m at eri als  (i. e.  t h e  cli nic al  pr ot oc ol,  C R Fs ),  e q ui p m e nt,  ex p eri e nc e  ( w h et h er  of  a  sci e ntific,  
t ec h nic al, e n gi n e eri n g, o p er ati o n al, or c o m m erci al n at ur e), d esi g ns, s p ecific ati o ns, k n o w-h o w, 
pr o d uct  us es, pr oc ess es, f or m ul a e, c osts, fi n a nci al d at a, m ar k eti n g pl a ns a n d  dir ect  s elli n g 
s yst e ms, c ust o m er lists a n d t ec h nic al a n d c o m m erci al i nf or m ati o n r el ati n g t o c ust o m ers or 
b usi n ess  pr oj ecti o ns  us e d  b y  P erri g o  i n  its  b usi n ess.  A n y  d at a,  i n v e nti o ns,  or  disc o v eri es  
c oll ect e d or d e v el o p e d, as a r es ult of t his st u dy is c o nsi d er e d c o nfi d e nti al. T his c o nfi d e nti al 
i nf or m ati o n  s h all  r e m ai n  t h e  s ol e  pr o p ert y  of  P erri g o,  s h all  n ot  b e  discl os e d  t o  a n y  
u n a ut h oriz e d p ers o n or us e d i n a n y u n a ut h oriz e d m a n n er wit h o ut writt e n c o ns e nt of P erri g o, 
a n d s h all n ot b e us e d exc e pt i n t h e p erf or m a nc e of t h e st u d y.  As s uc h, c o nfi d e nti al st u d y -
r el at e d  i nf or m ati o n  s h o ul d  n ot  b e  i ncl u d e d  o n  t h e  c urric ul u m  vit a e  of  a n y  p artici p ati n g  
i n v esti g at or or st u d y st aff. 
 
T h e  i nf or m ati o n  d e v el o p e d  d uri n g  t h e  c o urs e  of  t his  cli nic al  st u dy  is  als o  c o nsi d er e d  
c o nfi d e nti al, a n d will b e us e d b y P erri g o i n c o n n ecti o n wit h t h e d e v el o p m e nt of t h e dr u g.  T h e 
i nf or m ati o n  m a y  b e  discl os e d  as  d e e m e d  n ec ess ar y  b y  P erri g o  t o  all o w  t h e  us e  of  t he 
i nf or m ati o n d eri v e d fr o m t his cli nic al st u d y, t h e i n v esti g at or is o bli g e d t o pr o vi d e P erri g o wit h 
c o m pl et e t est r es ults a n d all d at a d e v el o p e d i n t h e st u d y. T h e i nf or m ati o n o bt ai n e d d uri n g t his 
st u d y m a y b e m a d e a v ail a bl e t o ot h er i n v esti g at ors w h o ar e c o n d ucti n g si mil ar st u di es. 
 
T h e  i n v esti g at or  s h all  n ot  m a k e  a n y  p u blic ati o n  r el at e d  t o  t his  st u d y  wit h o ut  t h e  ex pr ess  
writt e n p er missi o n of P erri g o.  
 
 
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 4 8  of 5 1  
Pr ot oc ol: P R G -N Y -1 5 -0 0 7  
  P a g e 4 9  of 5 1 I N V E S TI G A T O R A G R E E M E N T 
 
P R O T O C OL N U M B E R:  P R G -N Y - 1 5-0 0 7  
 
P R O T O C OL TI TL E:  A R a n d o miz e d, D o u bl e -Bli n d e d, V e hicl e -C o ntr oll e d, P ar all el -Gr o u p 
M ultic e nt er St u d y T o C o m p ar e P erri g o U K FI N C O’s Estr a di ol V a gi n al Cr e a m 0. 0 1 % T o E S T R A C E® 
( estr a di ol) V a gi n al Cr e a m, U S P, 0. 0 1 % (W ar n er C hilc ott ( U S),  LL C) A n d B ot h Acti v e Tr e at m e nts 
T o A V e hicl e C o ntr ol I n T h e Tr e at m e nt Of V ul v ar A n d V a gi n al Atr o p h y  
 
 
I  h a v e  c ar ef ull y  r e a d  t h e  f or e g oi n g  pr ot oc ol  a n d  a gr e e  t h at  it  c o nt ai ns  all t h e  n ec ess ar y  
i nf or m ati o n f or c o n d ucti n g t his st u d y s af el y.  I will c o n d uct t his st u d y i n strict acc or d a nc e wit h 
t his pr ot oc ol, I C H G ui d eli n es f or G o o d Cli nic al Pr actic es, t h e C o d e of F e d er al R e g ul ati o ns, t h e 
H e alt h  I ns ur a nc e  P ort a bilit y  a n d  Acc o u nt a bilit y  Act  ( HI P A A)  a n d  a n y  l oc al  r e g ul at or y  
r e q uir e m e nts a n d will att e m pt t o c o m pl et e t h e st u d y wit hi n t h e ti m e d esi g n at e d.  I will pr o vi d e 
acc ess t o c o pi [INVESTIGATOR_1309] t h e pr ot oc ol a n d all ot h er i nf or m ati o n r el ati n g t o pr e -cli nic al a n d pri or 
cli nic al ex p eri e nc e s u b mitt e d b y P erri g o t o all p ers o n n el r es p o nsi bl e t o m e w h o p artici p at e i n 
t h e st u d y.  I will disc uss t his i nf or m ati o n wit h t h e m t o ass ur e t h at t h e y ar e a d e q u at el y i nf or m e d 
r e g ar di n g t h e dr u g a n d c o n d uct of t h e st u d y.  I a gr e e t o k e e p r ec or ds o n all s u bj ect i nf orm ati o n 
i n acc or d a nc e wit h F D A r e g ul ati o ns. 
 
 
 
    
    Pri nci p al I n v esti g at or’s Pri nt e d N a m e  
 
 
 
    
    Pri nci p al I n v esti g at or’s Si g n at ur e  
 
 
    
    D at e  
  
Pr ot oc ol: P R G -N Y -[ADDRESS_29330] aft G ui d a nc e o n Estr a di ol. ( Estr a di ol Cr e a m 0. 0 1 % 
V a gi n al) – R ec o m m e n d e d A u g 2 0 0 9 ; R e vis e d S e p [ADDRESS_29331] u g A d mi nistr ati o n. G ui d a nc e f or t h e I n d ustr y. Estr o g e n a n d 
Estr o g e n/ Pr o g esti n Dr u g Pr o d ucts t o Tr e at V as o m ot or S y m pt o ms a n d V ul v ar a n d 
V a gi n al Atr o p h y S y m pt o ms — R ec o m m e n d ati o ns f or Cli nic al E v al u ati o n  
3.  N ort h A m eric a n M e n o p a us e S oci et y. T h e r ol e of l oc al v a gi n al estr o g e n f or tr e at m e nt of 
v a gi n al atr o p h y i n p ost m e n o p a us al w o m e n: [ADDRESS_29332] at e m e nt of T h e N ort h 
A m eric a n M e n o p a us e S oci et y. M e n o p a us e. 2 0 0 7; 1 4( 3 Pt 1): [ADDRESS_29333] m e n o p a us al 
w o m e n: [ADDRESS_29334] at e m e nt of T h e N ort h A m eric a n M e n o p a us e S oci et y. 
M e n o p a us e 2 0 0 7; 1 4( 2): [ADDRESS_29335] at e m e nt of 
T h e N ort h A m eric a n M e n o p a us e S oci et y. M e n o p a us e. 2 0 1 2 M ar; 1 9  ( 3): 2 5 7-7 1.  
6.  B ac h m a n n G A, L o b o R A, G ut R, N ac hti g all L, N ot el o vitz M: Effic acy of l o w -d os e Estr a di ol 
v a gi n al t a bl ets i n t h e tr e at m e nt of atr o p hic v a gi nitis. O bst etrics & G y n ec ol o g y V ol. 1 1 1, 
N o 1, J a n 2 0 0 8: [ADDRESS_29336] ai nts. I n: L o b o R A, e d. Tr e at m e nt 
of t h e P ost m e n o p a us al W o m a n: B asic a n d Cli nic al As p ects. P hil a d el p hi a, P A: Li p pi [INVESTIGATOR_30008] a ms & Wil ki ns, 1 9 9 9: [ADDRESS_29337] ei n J: U p d at e o n v a gi n al atr o p h y. 
M e n o p a us e, S e p/ Oct [ADDRESS_29338] c a nc er s ur vi v ors b e tr e at e d wit h t o pic al estr o g e ns ? O nc ol o gist 2 0 0 8; 1 3( 3): [ADDRESS_29339] m e n o p a us al w o m e n, J 
W o m e n’s H e alt h  (L ars h mt). 2 0 1 0; 1 9( 3): 4 2 5-4 3 2  
1 2.  L y nc h C. V a gi n al estr o g e n t h er a p y f or t h e tr e at m e nt of atr o p hic v a gi nitis. J W o m e n’s 
H e alt h, 2 0 0 9; 1 8( 1 0): [ADDRESS_29340] et G y n ec ol. 2 0 0 8 N o v;  1 1 2  
( 5): [ADDRESS_29341] e m atic R e vi e w 2 0 0 3/ 2 0 0 5( 4)  
[ADDRESS_29342] et G y n ec ol. 1 9 9 9 N o v; 9 4  ( 5 Pt 1): [ADDRESS_29343] m e n o p a us e — cyt ol o g y, 
hist ol o g y a n d p H as m et h o ds of ass ess m e nt. M at urit as 1 9 9 5;  2 1: 5 1 – 6.  
[ADDRESS_29344];  1 0 2  ( 4): 8 2 3-3 4.  
1 8.  J a n et A C h oll et Effic acy a n d s af et y of ultr a-l o w-d os e V a gif e m( 1 0 mc g). 2 0 1 1; 5: 5 7 1 – 5 7 4.  
Pr ot oc ol: P R G -N Y -[ADDRESS_29345] u d y: R e pl e ns v ers us l oc al estr o g e n i n m e n o p a us al w o m e n. 
F ertil St eril 1 9 9 4;  6 1: [ADDRESS_29346] m e n o p a us al ur o g e nit al 
atr o p h y. BJ O G 1 9 9 6; 1 0 3: 3 5 1 -3 5 8.  
2 1.  N ac hti g all L. Cli nic al tri al of t h e estr a di ol v a gi n al ri n g i n t h e U. S. M at urit as 1 9 9 5;  
2 2( S u p pl): S [ADDRESS_29347] m e n o p a us al w o m e n: a c o m p ar ati v e st u d y. J O bst et G y n a ec ol R es 
2 0 0 1;  2 7: [ADDRESS_29348] ei n b er g W M, H e p b ur n D S. 1 7 A - estr a di ol v a gi n al 
t a bl et v ers us c o nj u g at e d e q ui n e estr o g e n v a gi n al cr e a m t o r eli e v e m e n o p a us al atr o p hic 
v a gi nitis. M e n o p a us e 2 0 0 0; 7: [ADDRESS_29349] et G y n ec ol 
R e pr o d Bi ol 1 9 9 7;  7 1: 7 3 -8 0.  
2 5.  Cr a n d all C. V a gi n al estr o g e n pr e p ar ati o ns: a r e vi e w of s af et y a n d effic acy f or v a gi n al 
atr o p h y. J W o m e n’s H e alt h 2 0 0 2; 1 1: 8 5 7 -8 7 7  
2 6.  Eri ks e n P S, R as m uss e n H. L o w -d os e 1 7 β -estr a di ol v a gi n al t a bl ets i n t h e tr e at m e nt of 
atr o p hic v a gi nitis: a d o u bl e -bli n d pl ac e b o c o ntr oll e d st u d y. E ur J O bst et Gy n ec ol R e pr o d 
Bi ol 1 9 9 2; 4 4: 1 3 7 -1 4 4  
2 7.  C as p er F, P etri E. L oc al tr e at m e nt of ur o g e nit al atr o p h y wit h Estr a di o l-r el e asi n g v a gi n al 
ri n g: a c o m p ar ati v e a n d a pl ac e b o c o ntr oll e d m ultic e nt er st u d y. V a gi n al Ri n g St u d y 
Gr o u p. I nt Ur o g y n ec ol J 1 9 9 9: 1 0: [ADDRESS_29350] et G y n a ec ol 
C a n. 2 0 0 4 M a y; 2 6( 5): [ADDRESS_29351] u g I nf or m ati o n J, 
2 0 1 0; 4 4: [ADDRESS_29352] ei n J – U p d at e o n v a gi n al atr o p h y, 
M e n o p a us e m a n a g e m e nt 2 0 0 5  
3 1.  Estr ac e v a gi n al cr e a m 0. 0 1 % p ac k a g e i ns ert d at e d J u l y 2 0 1 1 
3 2.  Cli nic al Tri als. g o v I d e ntifi er: N C T 0 2 1 9 5 9 8 6: A C o m p aris o n of Estr a di ol V a gi n al Cr e a m t o 
Estr ac e ® Cr e a m i n [ADDRESS_29353] m e n o p a us al F e m al es wit h Atr o p hic V a gi nitis; L ast v erifi e d 
d at e: J ul y 2 0 1 4  